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Iron (Fe(II))- and 2-oxoglutarate (2OG)-dependent dioxygenases 
The iron and 2-oxoglutarate (Fe(II)/2OG)-dependent dioxygenases constitute a large 
family of enzymes which catalyze oxidation reactions. Characteristic for this family is their 
catalytic requirement for non-heme ferrous iron (Fe(II)) as co-factor and 2-oxoglutarate 
(2OG) as co-substrate. Crystallographic structure analyses of multiple family members have 
revealed these enzymes to possess a common core fold, the double-stranded beta-helix 
(DSBH) fold (Figure 1A), which forms a distorted, barrel-shaped structure from two 
antiparallel ȕ-sheets (reviewed in McDonough et al. (2010)). In most cases, additional 
secondary structure elements or domains are involved in substrate binding. Such elements 
include subfamily-specific inserts between the ȕIV and ȕV strands or, less frequently, other ȕ-
strands. The length of these inserts vary from a few amino acids (Elkins et al., 2003), to fully 
functional domains (Elkins et al., 2002). Similarly, additional elements or domains are also 
commonly found N- or C-terminally to the core. In the more open end of the barrel, the 
DSBH core comprises a conserved Fe(II)-chelating 2-His-1-carboxylate active site motif, in 
which the carboxylate is from the side chain of aspartic acid or, less frequent, glutamic acid 
(Hegg and Que 1997). This motif is known as the “facial triad” because the three iron 
coordination sites are arranged to constitute one octahedral face (Hegg and Que 1997). The 
three remaining sites are left to accommodate other endogenous ligands or exogenous ligands 
originating from water, 2OG, prime substrate or O2. The large flexibility of the Fe(II)/2OG 
dioxygenase fold, reflected by the structure of the facial triad, explains the great versatility of 
this enzyme family with respect to chemical transformations and substrate recognition. 
The consensus catalytic mechanism of Fe(II)/2OG-dependent dioxygenases (Figure 
1B) involves initial binding of 2OG to the active site Fe(II) in a bidentate fashion, leading to 
displacement of two water molecules. This is thought to facilitate binding of prime substrate 
and, upon subsequent binding of O2, oxidative decarboxylation of 2OG results in a reactive 
Fe(IV)-oxo species which accomplishes substrate oxidation with reduction of Fe(IV) to 
Fe(II). Dissociation of the oxidized product, the co-product succinate and CO2 completes the 
catalytic cycle. However, the detailed reaction mechanisms can vary slightly between 
different family members, even between two enzymes acting on the same substrate (Neidig et 
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al., 2006). In animals, Fe(II)/2OG-dependent dioxygenases perform C-hydroxylations or 
hydroxylation-mediated N-demethylations of amino acid side chains and nucleic acid bases, 
as well as lipid hydroxylations. In microorganisms and plants, they have also been reported to 
perform more complex oxidation reactions such as cyclizations (Zhang et al., 2000), 
desaturations (Clifton et al., 2003; Sleeman et al., 2004) and halogenations (Vaillancourt et 




Figure 1. Structure and catalytic mechanism of Fe(II)/2OG-dependent dioxygenases. A) General 
structure of the double-stranded beta-helix (DSBH) core fold. B) Binding of primary substrate is 
preceded by 2-oxoglutarate (2OG) binding. Subsequent binding of O2 and oxidative decarboxylation of 
2OG results in a reactive Fe(IV)=O intermediate which oxidizes the substrate, while reducing Fe(IV) to 
Fe(II). Release of succinate and hydroxylated product enables successive reaction cycles. Adapted 
from Aik et al. (2012). 
13 
 
As a result of the diversity of the chemical reactions catalyzed by Fe(II)/2OG-
dependent dioxygenases, such enzyme activity is central in a great number of biological 
processes. In addition to their well-known roles in fatty acid metabolism (Hulse et al., 1978) 
and post-translational modification of collagen (Hutton et al., 1966; Hutton et al., 1967), 
recent findings have also linked these enzymes to hypoxic signaling (Ivan et al., 2001; 
Jaakkola et al., 2001), DNA repair (Falnes et al., 2002; Trewick et al., 2002), epigenetic gene 
regulation (Tsukada et al., 2006; Yu et al., 2007; Tahiliani et al., 2009), mRNA splicing (Jia 
et al., 2011; Zheng et al., 2012) and tRNA hypermodification (Fu et al., 2010; van den Born et 
al., 2011). 
Here, the functions of some of the proteins in this fascinating enzyme family will be 
described in further detail. 
AlkB proteins 
E. coli AlkB 
The alkB gene was first identified in a screen isolating Escherichia coli (E. coli) 
mutants sensitive to the SN2 alkylating agent methyl methanesulphonate (MMS) (Kataoka et 
al., 1983). Although initial progress was made in terms of cloning the gene and purifying the 
encoded protein (Kataoka and Sekiguchi 1985), the precise role of AlkB in alkylation 
resistance remained enigmatic. However, the original assumption that AlkB per se could be 
an alkylation damage repair enzyme was supported when human cell lines over-expressing 
AlkB was shown to display increased resistance to MMS (Chen et al., 1994). A leap in 
direction of elucidating the AlkB function came with the finding that alkB mutants were 
defective in reactivation of MMS-inactivated single-stranded, but not double-stranded, DNA 
bacteriophages (Dinglay et al., 2000). As the N1 position in purines and N3 position in 
pyrimidines are engaged in Watson-Crick base-pairing, and thus protected from the effect of 
SN2 agents in double-stranded DNA, this indicated that the base lesions 1-methyladenine (1-
meA) and 3-methylcytosine (3-meC) could be the AlkB substrates. Soon after, the ultimate 
clue to identification of the AlkB function was provided when a bioinformatics report placed 
the protein in the superfamily of Fe(II)- and 2-oxoglutarate (2OG)-dependent dioxygenases 
(Aravind and Koonin 2001). Consequently, nearly two decades after the initial identification 
of AlkB, two groups independently determined its function in repair of 1-meA and 3-meC 
lesions in single-stranded DNA (Falnes et al., 2002; Trewick et al., 2002). 
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AlkB catalyzes oxidation of the aberrant methyl group, resulting in an unstable 
hydroxymethyl group which is spontaneously released as formaldehyde, thereby regenerating 
the undamaged base (Figure 2). This oxidative demethylation reaction requires ferrous iron as 
co-factor and 2-oxoglutarate as co-substrate, and the oxidizing agent molecular oxygen. 
Decarboxylation of 2OG to succinate and CO2 is coupled to oxidation of the primary 
substrate. The discovery of the AlkB function revealed a novel mechanism for direct reversal 




Figure 2. Reaction mechanism of E. coli AlkB. AlkB reverses damaging alkyl groups in the N1-
position of purines and the N3-position of pyrimidines, here illustrated by 1-meA and 3-meC, in DNA or 
RNA. The methyl group is oxidized in presence of Fe(II), 2-oxoglutarate (2OG) and O2, resulting in its 
destabilization and spontaneous release as formaldehyde (HCHO), thereby regenerating the 
undamaged base. Decarboxylation of 2OG to succinate and CO2 is coupled to substrate oxidation. 
Adapted from Trewick et al. (2002). 
The crystal structure of AlkB in complex with a single-stranded, 1-meA-containing 
DNA trinucleotide, Fe(II) and 2-oxoglutarate confirmed the structural prediction by Aravind 
and Koonin that its catalytic core adapts the DSBH fold typical for the Fe(II)/2OG-dependent 
dioxygenases (Aravind and Koonin 2001; Yu et al., 2006). This structure further verified the 
presence of two motifs predicted by Aravind and Koonin: the Fe(II)-chelating HXDXnH triad 
(His131, Asp133 and His187), as well as the AlkB-specific RX5R motif (Arg204 and Arg210) 
which is involved in coordination of 2OG (Aravind and Koonin 2001; Yu et al., 2006). 
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Subsequently, another AlkB structure, complexed with double-stranded DNA, gave further 
insight into the means by which AlkB binds its substrate (Yang et al., 2008). This report 
revealed the basis for the preference of AlkB for single-stranded substrates, as the enzyme 
primarily interacts with the damaged strand. Moreover, AlkB-mediated compression of the 
two bases flanking the lesion site leads to their stacking, as well as facilitating flipping of the 
base to be repaired into the active enzyme site. 
Although less efficiently, AlkB also acts on the structural 1-meA and 3-meC analogs 
1-methylguanine (1-meG) and 3-methylthymine (3-meT), thus suggesting the former to be the 
primary substrates (Delaney and Essigmann 2004; Falnes 2004; Koivisto et al., 2004). 
Subsequent reports have further extended the substrate repertoire to also comprise bulkier 
lesions, as AlkB also acts on ethyl- and propyl-lesions, as well as exocyclic etheno- and 
ethano-adducts (Koivisto et al., 2003; Delaney et al., 2005; Frick et al., 2007). In addition to 
this rather broad substrate specificity in DNA, AlkB is also active on RNA (Aas et al., 2003). 
AlkB-mediated RNA demethylation was further shown to reactivate MMS-inactivated RNA 
bacteriophages, thus demonstrating that AlkB also displays in vivo repair activity towards 
alkylated RNA (Aas et al., 2003). Another report, further supporting biological importance of 
RNA repair, showed that AlkB can functionally recover both mRNA and tRNA molecules 
previously inactivated by chemical methylation (Ougland et al., 2004). These intriguing 
discoveries have inevitably revived the debate concerning the biological role of RNA repair, a 
debate which is still ongoing. 
The alkB gene is part of the so-called adaptive response to alkylation damage, which 
also includes three other genes, ada, alkA and aidB (reviewed in Sedgwick and Lindahl 
(2002)). Like AlkB, both Ada and AlkA are DNA repair proteins (McCarthy et al., 1984; 
Demple et al., 1985). AidB has been suggested to be involved in detoxification of alkylating 
agents rather than in repair of the damaged DNA (Landini et al., 1994). Positive regulation of 
the adaptive response is provided by Ada, an alkyltransferase which mediates non-enzymatic 
transfer of damaging methyl groups from DNA to certain cysteine residues within Ada itself 
(Lindahl et al., 1982). Methylated Ada then acts as a transcription factor to induce expression 
of the regulon comprising all four adaptive response genes (reviewed in Landini and Volkert 
(2000)). 
Mammalian AlkB homologs (ALKBHs) 
Based on sequence similarity, nine homologs of the E. coli AlkB protein, ALKBH1-8 
and FTO, have so far been identified in mammals (Kurowski et al., 2003; Gerken et al., 
16 
 
2007). These proteins all display a double-stranded beta-helix (DSBH) jelly roll fold similar 
to that of AlkB and Fe(II)/2OG-dependent dioxygenases in general. However, the sequence 
homology is mainly restricted to the AlkB specific catalytic core motif, HXDXnH…RX5R, 
which is conserved in the mammalian homologs. The phylogenetic relationship of ALKBH 
proteins is shown in Figure 3. A brief description of each homolog is given below, and their 
main substrates and functions are summarized in Table 1. 
 
 
Figure 3. Phylogenetic relationship between mammalian ALKBH proteins. The more distantly 
related FTO protein is indicated with a dotted line. Adapted from Kurowski et al. (2003). 
ALKBH1 
ALKBH1, the homolog with the highest similarity to E. coli AlkB was also the first 
mammalian AlkB protein to be discovered (Wei et al., 1996). Despite the high sequence 
similarity between the two, a function of ALKBH1 in DNA repair is debated. The initial 
report suggested it to be a functional AlkB homolog since its expression partially rescued 
alkB mutant E. coli cells from MMS-induced cell death (Wei et al., 1996). Supporting this, 
another group reported this enzyme to be a functional mitochondrial AlkB homolog 
possessing 3-meC demethylase activity towards both DNA and RNA (Westbye et al., 2008). 
However, this DNA repair activity was very weak and never reproduced by others. 
Interestingly, two studies using gene-targeted mice rather pointed towards a role of ALKBH1 
in embryogenic gene regulation (Pan et al., 2008; Nordstrand et al., 2010). In the first of 
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these, disruption of placental trophoblast differentiation was observed in Alkbh1-targeted mice 
(Pan et al., 2008). Additionally, they showed localization of Alkbh1 to nuclear euchromatin as 
well as its binding to the placental gene repressor Mrj which exerts its effect through 
recruitment of type II histone deacetylases (HDACs). Mutually exclusive interaction of 
Alkbh1 and HDAC5 to Mrj thus suggested a stimulatory effect of Alkbh1 on placental 
trophoblast lineage differentiation. The second study revealed Alkbh1-deficient mice to 
display sex-ratio distortion against females, unilateral developmental defects in the eye and 
skeleton, and, consistently, embryonic misexpression of bone morphogenetic proteins 
(Bmps), thus Alkbh1 was suggested to be a histone demethylase functioning during 
embryogenesis and spermatogenesis (Nordstrand et al., 2010). Very recently, this 
controversial proposal of ALKBH1 possessing a histone substrate was supported, as histone 
H2A was demonstrated to stimulate decarboxylation of 2-oxoglutarate by recombinant 
Alkbh1, and H2A purified from Alkbh1-deficient, but not wild-type, mouse embryonic 
fibroblast (MEF) cells displayed dimethyl groups on certain lysine residues (Ougland et al., 
2012). Consistently, repression of a Piwi-interacting RNA (piRNA) cluster in spermatocytes 
by Alkbh1 and the testis-specific transcription repressor Tzfp was also reported, in which the 
contribution of Alkbh1 was suggested to be chromatin structure alteration by demethylation 
of histone H2A (Nordstrand et al., 2012). 
In addition to its demethylase activity, ALKBH1 possesses in vitro DNA lyase 
activity, cleaving DNA at abasic (AP) sites in both ssDNA and dsDNA to generate strand 
breaks (Muller et al., 2010). This activity is not dependent on Fe(II) and 2OG, suggesting it to 
be ascribed to a second active site. The biological relevance of this activity is, however, not 
known.  
ALKBH2 and ALKBH3 
With the identification of ALKBH2 and ALKBH3, humans were shown to possess 
two proteins with the ability to complement reactivation of an MMS-inactivated single-
stranded DNA bacteriophage in an alkB mutant E. coli strain as well as to remove 1-meA and 
3-meC from single-stranded DNA by oxidative demethylation (Duncan et al., 2002; Aas et 
al., 2003). Different substrate specificities have been shown for the two homologs, and while 
ALKBH2 prefers double-stranded substrates, single-stranded ones are favored by ALKBH3 
(Aas et al., 2003; Falnes et al., 2004). Furthermore, while ALKBH2 is exclusively active on 
DNA, ALKBH3 also reverses alkylation damage in RNA substrates (Aas et al., 2003). In 
addition, ALKBH3 was, like E. coli AlkB, able to both reactivate the MMS-alkylated single-
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stranded RNA phage MS2 in alkB deficient E. coli cells and recover the functions of 
alkylation-inactivated mRNA and tRNA molecules in the processes of translation and 
aminoacylation (Ougland et al., 2004). Notably, AlkB proteins have also been identified in 
viruses with RNA genomes, further supporting a biological significance of RNA repair 
(Aravind and Koonin 2001). 
The crystal structures of ALKBH2 and AlkB in complex with dsDNA revealed that 
ALKBH2, in contrast to AlkB, interacts extensively with the non-damaged strand, thus 
explaining the basis of the ALKBH2 preference for double-stranded substrates (Yang et al., 
2008). Additionally, structural differences were found in the base flipping mechanisms of the 
two enzymes: while AlkB distorts the DNA backbone to allow stacking of the residues 
flanking the damage site, the corresponding base gap is filled by intercalation of an aromatic 
residue (Phe102) in ALKBH2 (Yang et al., 2008). Furthermore, the structure of ALKBH3 in 
absence of DNA/RNA has been solved (Sundheim et al., 2006). However, its superimposition 
onto those of AlkB and ALKBH2 surprisingly revealed the structure of the ALKBH3 active 
site to be most similar to that of ALKBH2, as both human proteins, but not AlkB, display a 
divergent ȕ-hairpin loop close to the substrate binding groove (Sundheim et al., 2008; Yang et 
al., 2008). The combination of motif-swapping and mutagenesis analysis demonstrated that 
the hairpin is a determinant of substrate specificity, and acidic residues (Arg101-Glu102-
Asp103) in the ALKBH3 hairpin provide the structural basis for its single-strand preference, 
while the responsibility for stabilization and base-flipping of double-stranded ALKBH2 
substrate was ascribed to a hydrophobic network partially composed of the hairpin loop (Chen 
et al., 2010; Monsen et al., 2010). Notably, the absence of this hairpin in AlkB might explain 
its broader substrate specificity relative to ALKBH3 (Mishina et al., 2005). 
Moreover, the ALKBH3 structure further revealed auto-hydroxylation of an essential 
leucine residue (Leu177) in the active site, which was proposed to serve as an inactivating 
switch to prevent formation of damaging oxygen radicals in the absence of substrate 
(Sundheim et al., 2006).  
Distinct biological roles of ALKBH2 and ALKBH3 are indicated not only by their 
substrate preferences, but also by their different subcellular localization patterns. While 
ALKBH2 is generally distributed evenly throughout the nucleoplasm, cell-cycle dependent 
relocation to replication foci occurs in S-phase cells (Aas et al., 2003). ALKBH3, however, 
localizes mainly to the nucleoplasm, with partial cytoplasmic occurrence as well as general 
exclusion from nucleoli. Thus, the two proteins likely function in DNA repair during 
replication and transcriptional maintenance of single-stranded DNA/RNA, respectively, and 
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appear to together cover the cellular functions performed by AlkB in E. coli (Aas et al., 2003). 
Supporting this suggestion of ALKBH2 being the main enzyme to reverse genomic 1-meA 
and 3-meC, increased accumulation of 1-meA under normal physiological conditions was 
observed in Alkbh2-targeted mice with respect to wild-type as well as Alkbh3-targeted mice 
(Ringvoll et al., 2006). Furthermore, Alkbh2-, but not Alkbh3-targeted, MEF cells displayed 
reduced repair kinetics after MMS-treatment (Ringvoll et al., 2006), and only ALKBH2 
complemented reversal of etheno adducts in alkB deficient E. coli cells (Ringvoll et al., 2008). 
However, in addition to the role of ALKBH3 in RNA repair, the enzyme was recently 
suggested to function in biological maintenance of genome integrity in a subset of cancer cell 
lines in which it reverses 3-meC in dsDNA previously unwinded, and thus made single-
stranded, by the 3’-5’ DNA helicase activating signal cointegrator complex subunit 3 
(ASCC3) to ensure proliferation (Dango et al., 2011). 
ALKBH4-ALKBH7 
Four homologs, ALKBH4, ALKBH5, ALKBH6 and ALKBH7, have all been scarcely 
studied and their functions are still unknown. These proteins are, based on primary sequence, 
more similar to ALKBH2/ALKBH3 than to E. coli AlkB/ALKBH1 (Kurowski et al., 2003) 
(Figure 3). Moreover, ALKBH5/ALKBH7 and ALKBH4/ALKBH6/ALKBH8 are in-
paralogs, meaning they originated from gene duplication subsequent to the initial radiation of 
the AlkB lineage (Kurowski et al., 2003). In an initial functional study of these homologs, no 
in vitro activity towards 1-meA and 3-meC was detected for the successfully purified 
recombinant human ALKBH4, ALKBH6 and ALKBH7 proteins (Lee et al., 2005). However, 
subcellular localization to the nucleus as well as the cytoplasm has been reported for green 
fluorescent protein (GFP) fusions of all four homologs, indicating the possibility of nuclear 
functions (Tsujikawa et al., 2007). Furthermore, ALKBH5 has previously, together with 
ALKBH6, been suggested to target nucleic acids, as they, like the AlkB proteins known to 
repair DNA, display high pI values which are compatible with and potentially important for 
DNA association (Sedgwick et al., 2007). Likewise, the relatively low pI values of ALKBH4 
and ALKBH7 could possibly disfavour their DNA binding abilities, and these proteins were 
consequently proposed to rather act on proteins (Sedgwick et al., 2007). We recently 
demonstrated uncoupled 2-oxoglutarate decarboxylase activity of human ALKBH4 in absence 
of prime substrate, suggesting this protein to be a bona fide Fe(II)/2OG-dependent 
dioxygenase (Bjornstad et al., 2011). Another recent study reported uncoupled 2-oxoglutarate 
decarboxylation by ALKBH5, which was further indicated to possess a regulatory role in the 
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cellular hypoxia response, as ALKBH5 was the only ALKBH gene to be induced by hypoxia 
inducible factor-1Į (HIF-1Į) under hypoxic conditions (Thalhammer et al., 2011). Very 
recently, supporting the previously proposed activity of ALKBH5 towards nucleic acids, the 
protein was shown to demethylate N6-methyladenine (6-meA) in mRNA both in vitro and in 
vivo (Zheng et al., 2012). ALKBH5 deficiency was further demonstrated to perturb mRNA 
export, RNA metabolism and mRNA processing factor assembly in addition to 
spermatogenesis (Zheng et al., 2012). In conclusion, it appears likely that at least some of the 
uncharacterized homologs are involved in processes other than DNA repair, and that the 
target repertoire of the ALKBH protein family will expand in the future to include proteins in 
addition to nucleic acids. 
ALKBH8 
As the only AlkB homolog, ALKBH8 comprises two annotated functional domains in 
addition to the AlkB domain, these being an RNA recognition motif (RRM) and an S-
adenosyl methionine (SAM)-dependent methyltransferase (MT) domain (Tsujikawa et al., 
2007). Moreover, ALKBH8 is also the only one displaying an exclusively cytoplasmic 
localization (Tsujikawa et al., 2007). The MT domain displays sequence similarity to the S. 
cerevisiae Trm9 protein, which has previously been shown to catalyze methylesterification of 
modified uridine nucleotides in the wobble position of the anti-codon loops of tRNAGly and 
tRNAArg, thus generating the 5-methoxycarbonylmethyluridine (mcm5U) modification as well 
as its derivative 5-methoxycarbonylmethyl-2-thiouridine (mcm5s2U) (Kalhor and Clarke 
2003). Alkbh8-targeted mice lack both these tRNA modifications as well as the 2’-O-ribose-
methylated form of mcm5U (mcm5Um) (Songe-Moller et al., 2010). Through investigation of 
recombinant ALKBH8 domains, the ALKBH8-MT activity was shown to be responsible for 
the final methylation step in generation of the mcm5U modification, and this activity was 
further shown to strictly depend on TRM112, a small protein subunit also required for the 
function of other tRNA and protein methyltransferases (Fu et al., 2010; Songe-Moller et al., 
2010). 
In mammals, the mcm5U and mcm5Um modifications exist also in tRNASec, which 
decodes the UGA stop codon as the so-called 21st amino acid selenocysteine (Sec) during 
translation of selenoproteins (reviewed in Hatfield et al. (2006)). The mcm5Um/mcm5U ratio 
is likely important for efficient selenoprotein synthesis, and consistently, the Alkbh8-targeted 
mice showed decreased expression of the selenoprotein GPx1 (Songe-Moller et al., 2010). 
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Soon after the elucidation of the ALKBH8-MT activity, a recombinant Alkbh8 version 
in which the MT domain was deleted (RRM-AlkB) was demonstrated to hydroxylate mcm5U 
into (S)-mchm5U in a synthetic tRNAGly anticodon loop-resembling substrate (Fu et al., 2010). 
Furthermore, using mice engineered to separately express the two domains (MT or AlkB), the 
AlkB domain was found to hydroxylate mcm5U previously generated from cm5U by the MT 
domain, resulting in the (S)-mchm5U modification in tRNAGly (van den Born et al., 2011). 
Thus, the MT and AlkB domains of ALKBH8 act sequentially to first generate the wobble 
position modification mcm5U in a subset of tRNA isoacceptors, which in tRNAGly is 
subsequently hydroxylated to (S)-mchm5U. 
Recently, increased insight into the RNA binding properties of ALKBH8 was 
provided with publication of the crystal structure of its RRM-AlkB moiety, demonstrating 
structural stabilization of the AlkB domain by a Zn(II)-binding cysteine cluster in its C-
terminus as well as formation of a unified interaction surface by the RRM and AlkB domains, 
mediating contact with the tRNA substrate (Pastore et al., 2012). Through additional 
thermodynamic and crystallographic analysis, the authors found the RRM motif together with 
an N-terminal Į-helix preceding the RRM to contribute to unspecific RNA binding, while 
substrate specificity is likely rather provided by a structural fold spanning both the RRM 
motif and the AlkB domain (Pastore et al., 2012).  
In conclusion, the elucidation of ALKBH8 as a multifunctional RNA modification 
enzyme was the first definite evidence of ALKBH function extending beyond DNA repair.  
FTO 
A bioinformatics analysis of the fat mass- and obesity-associated (FTO) protein 
recently resulted in expansion of the mammalian AlkB family to include this protein as the 
ninth member. FTO was predicted to possess the characteristic DSBH fold containing both 
the iron-binding HXDXnH triad and the 2-oxoglutarate-coordinating RX5R motif in addition 
to a C-terminal domain without homology to any known protein sequence (Gerken et al., 
2007). FTO is associated with predisposition to obesity, which is explained by the presence of 
a common polymorphism in the first intron of the FTO gene (Frayling et al., 2007). The 
molecular mechanism behind the association of FTO with susceptibility to obesity has not yet 
been clarified, although a function in regulation of energy homeostasis has been proposed 
(Fischer et al., 2009). Such a function was suggested on the basis of the observation that Fto 
deficient mice displayed a lean phenotype with reduced fat mass, despite a relative increase in 
food intake and unchanged locomotor activity in comparison to wild-type mice (Fischer et al., 
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2009). Similarly, mice with higher Fto copy-number are obese, however, primarily as a result 
of increased food intake, with no significant changes in energy expenditure and locomotor 
activity (Church et al., 2010). Consistent with a role in nucleic acid demethylation, similar to 
the two functional AlkB homologs ALKBH2 and ALKBH3, FTO localizes to the nucleus 
(Gerken et al., 2007). Initial studies on its enzymatic activity reported FTO to display weak in 
vitro demethylase activity towards single-stranded, but not double-stranded, oligonucleotides 
containing 3-meT or 3-meU (Gerken et al., 2007; Jia et al., 2008). A slightly higher activity 
towards the methylated uridine- compared to thymidine-containing substrate, suggested that 
the biological substrate could be RNA (Jia et al., 2008).  
Explaining the preference for single-stranded substrates, the crystal structure of FTO 
in complex with 3-meT showed the presence of an additional substrate recognition loop, not 
present in AlkB, which would be in sterical conflict with the non-methylated strand (Han et 
al., 2010). The crystal structure also revealed the critical function of the FTO C-terminal 
extension in stabilization of the N-terminal domain to ensure its catalytic activity.  
Recently, Jia and co-workers described efficient in vitro oxidative demethylase 
activity by FTO towards N6-methyladenosine (6-meA) in synthetic ssDNA/RNA substrates 
(Jia et al., 2011). RNA was further experimentally demonstrated to be a biologically relevant 
target, as the 6-meA levels in cellular mRNA decreased in response to FTO over-expression, 
and a corresponding decrease was observed upon siRNA-mediated knock-down of FTO (Jia 
et al., 2011). Although the 6-meA modification is ubiquitously found in nuclear mRNAs, its  
 
Table 1. Overview of main substrates and functions of mammalian ALKBH proteins. 
Enzyme Main substrate(s) Function References 
ALKBH1 3-meC in ssDNA/RNA Methyl-lysine in H2A 
DNA/RNA repair 
Gene regulation 
Westbye et al., 2008 
Ougland et al., 2012 
ALKBH2 1-meA and 3-meC in dsDNA DNA repair Aas et al., 2003 Falnes et al., 2004 
ALKBH3 1-meA and 3-meC in ssDNA/RNA DNA/RNA repair 
Aas et al., 2003 
Falnes et al., 2004 
ALKBH4 ? ?  
ALKBH5 6-meA in mRNA mRNA export Zheng et al., 2012 
ALKBH6 ? ?  
ALKBH7 ? ?  
ALKBH8 
cm5U in tRNA 
mcm5U in tRNA tRNA modification 
Songe-Moller et al., 2010 
Fu et al., 2010a 
van den Born et al., 2011 
Fu et al., 2010b 




biological function is not fully understood. However, a recent report on the 6-meA patterns at 
the global transcriptome level showed this modification to be fundamental in the process of 
pre-mRNA splicing (Dominissini et al., 2012). Thus, novel data strongly suggest a functional 
role of FTO in regulation of gene expression rather than repair. 
Gene regulation from the perspective of Fe(II)/2OG-dependent 
dioxygenases 
Several Fe(II)/2OG-dependent dioxygenases display well established functions in gene 
regulation. Among these are proteins which act through modification of the chromatin 
structure to regulate transcription. Moreover, increasing evidence implies that other 
Fe(II)/2OG-dependent dioxygenases probably function in regulation of subsequent steps of 
gene expression (Figure 4). 
Chromatin structure and function 
DNA is present in the cell nucleus in the form of chromatin, a nucleoprotein complex 
which consists of histone proteins in addition to the DNA. The repetitive unit of chromatin is 
the nucleosome, which is composed of an octamer of two copies of each of the four core 
histones H2A, H2B, H3 and H4 around which 147 base pairs of DNA are wrapped twice 
(Luger et al., 1997), and the short stretch of DNA that couples adjacent core particles, the 
linker DNA, with its bound fifth histone protein, the linker histone H1 (Happel and Doenecke 
2009). The positively charged histone proteins form electrostatic interactions with the 
negative DNA molecule to stabilize the nucleosome from which the unstructured N-terminal 
tails of the otherwise globular core histones protrude (Luger and Richmond 1998). 
Furthermore, the linker histone is thought to be involved in stabilization of higher order 
chromatin structures (Robinson and Rhodes 2006). 
The hierarchical structure of chromatin reflects its function in DNA organization, and 
from a global perspective, chromatin is organized in two main structural domains, 
euchromatin and heterochromatin, which differ with respect to the degree of compaction. The 
majority of genes reside in the loosely packed, active euchromatin, in which they remain 
easily accessible. On the other hand, the far more condensed heterochromatin includes 
silenced elements such as repetitive sequences and transposons, and is also found in 
centromeric and telomeric chromosome regions (Martens et al., 2005; Schueler and Sullivan 





Figure 4. Proposed involvement of Fe(II)/2OG-dependent dioxygenases in regulation of gene 
expression. In addition to the JmjC-domain family of histone demethylases, DNA 
hydroxylases/demethylases in the TET family might also contribute to regulation at the chromatin 
level. While transcription is regulated in an oxygen-dependent manner through hydroxylation of the 
transcription factor HIF by FIH and PHD enzymes, post-transcriptional regulation might be performed 
by the mRNA demethylases ALKBH5 and FTO. Moreover, the tRNA hydroxylase ALKBH8 may 
function in regulation of translation, and proteins may be regulated post-translationally through 
modification by protein hydroxylases such as prolyl-3-hydroxylase (P3H) and prolyl-4-hydroxylase 
(P4H). Adapted from Loenarz and Schofield (2011). 
thus important to preserve genome integrity during cell division and to facilitate DNA-
dependent processes such as replication, transcription and DNA repair. This requirement is 
accommodated by the dynamics of the highly ordered chromatin structure which is, as 
described below, regulated through modification of its individual components. 
DNA modifications 
DNA is subjected to methylation at the 5-position in cytosine, resulting in 5-
methylcytosine (5-meC). The covalent attachment of a methyl group in this position is 
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performed by enzymes in the DNA methyltransferase (DNMT) family. The genomic DNA 
methylation pattern is initially established by the de novo methyltransferases DNMT3A and 
DNMT3B during early embryogenesis (Okano et al., 1999), and further transmitted through 
subsequent cell generations by the maintenance methyltransferase DNMT1 which targets 
newly synthesized, hemimethylated DNA in replication foci (Leonhardt et al., 1992). 
DNA methylation predominantly occurs in the context of CpG dinucleotide sequences. 
The CpG content of the vertebrate genome is asymmetrically distributed as a consequence of 
the mutagenic effect of 5-meC, which is frequently deaminated to thymine in a spontaneous 
manner (Coulondre et al., 1978; Bird 1980). Hence, CpG dinucleotides are predominantly 
clustered in CpG-rich regions, denoted CpG islands (CGIs), which are normally found in the 
unmethylated state (for a review, see Deaton and Bird (2011)). In the vertebrate genome, 
CGIs are associated with the promoters of ubiquitously expressed genes as well as many 
tissue-specific genes (Larsen et al., 1992; Zhu et al., 2008), and aberrant inactivation of such 
genes have been reported to correlate with methylation of their promoter CGIs in several 
cancers (Esteller 2007). Moreover, promoter CGI methylation is correlated with stable gene 
inactivation in processes such as X chromosome inactivation and imprinting (Edwards and 
Ferguson-Smith 2007; Reik 2007). Thus, 5-meC is generally viewed as a repressive 
epigenetic mark associated with long-term gene silencing. 
One mechanism by which 5-meC functions to inhibit gene expression is through the 
ability to directly prevent transcription factors to bind their target DNA sequences (Iguchi-
Ariga and Schaffner 1989; Prendergast and Ziff 1991). Additionally, this modification is 
recognized by methyl-CpG-binding proteins (MBPs) which further recruit chromatin 
remodeling factors and transcriptional repressors such as histone deacetylases (reviewed in 
Klose and Bird (2006)), thus also mediating gene inhibition in an indirect manner. 
However, 5-meC is also present beyond promoter CpG islands and even in non-CpG 
sites (Lister et al., 2009). Intriguingly, methylation of CpG islands located in gene bodies is, 
in contradiction with the silencing function of promoter CpG methylation, correlated with 
active gene expression, a contradiction which is known as the DNA methylation paradox 
(Jones 1999). Although the function of gene body methylation is still not fully known, it has 
been proposed to be a mechanism for silencing of transposable elements, as methylation of 
their start sites result in suppression while transcription of the host gene in which they reside 
is not affected (Yoder et al., 1997). Regulation of alternative splicing has been suggested as 
another possible function, as exon-intron boundaries display a marked decrease in the degree 
of methylation (Laurent et al., 2010). 
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Another modified DNA base is ȕ-D-glucopyranosyloxymethyluracil (base J), which is 
present in the genomes of certain protozoan parasites including trypanosomes, but has, 
notably, not been found in metazoans (van Leeuwen et al., 1998). Synthesis of this 
hypermodified base occurs in a two-step pathway in which the first step involves 
hydroxylation of thymidine in dsDNA by the Fe(II)/2OG-dependent dioxygenases J-binding 
protein (JBP) 1 and 2 (Yu et al., 2007; Cliffe et al., 2009; Vainio et al., 2009; Cliffe et al., 
2012). The resulting intermediate, 5-hydroxymethyluracil (5-hmU), is subsequently 
glycosylated by an unknown glycosyltransferase to form base J (Cliffe et al., 2012). A gene 
regulatory function of base J was suggested with the finding that a subfraction localizes to 
genomic regions flanking RNA Polymerase II (Pol II) transcription sites (Cliffe et al., 2010). 
JBP1/2 deletion studies revealed that loss of base J coincided with decreased nucleosome 
density as well as increased histone acetylation and promoter occupancy by Pol II, thus 
suggesting an epigenetic mechanism for base J-mediated repression of transcription initiation 
(Ekanayake and Sabatini 2011; Ekanayake et al., 2011). 
DNA methylation reversal 
Although DNA methylation was traditionally considered a stable epigenetic mark, it is 
now broadly accepted that the two stages of epigenetic reprogramming that takes place during 
mammalian embryonic development involve an active mechanism for reversal of cytosine 
methylation, as suggested by the reported observations of rapid depletion of 5-meC in the 
paternal pronucleus of the zygote prior to the first mitosis, as well as a similar global 5-meC 
reduction during gametogenesis (Mayer et al., 2000; Oswald et al., 2000; Hajkova et al., 
2002). Additionally, active demethylation has also been suggested to occur gene specifically 
in somatic cells (Bruniquel and Schwartz 2003). However, no demethylase with specificity 
for 5-meC has yet been discovered, despite an intense search for responsible enzymes. 
The discovery that the human ten-eleven translocation 1 (TET1) protein catalyzes 
conversion of 5-meC to 5-hydroxymethylcytosine (5-hmC) was important for the 
understanding of the dynamics of the 5-meC modification (Figure 5A) (Tahiliani et al., 2009). 
The mammalian TET proteins (TET1, TET2 and TET3) compose a subfamily of the 
Fe(II)/2OG-dependent dioxygenases, and all three enzymes have been reported to possess 5-
meC hydroxylase activity in presence of Fe(II) and 2-oxoglutarate (Tahiliani et al., 2009; Ito 
et al., 2010). Moreover, these proteins can further oxidize 5-hmC to 5-formylcytosine (5-fC) 
and 5-carboxylcytosine (5-caC, Figure 5A), thus generating two additional cytosine 
derivatives (He et al., 2011; Ito et al., 2011). As an attractive alternative to direct 
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demethylation of 5-meC, one could imagine an additional last step in which 5-caC is further 
decarboxylated to recover the unmodified cytosine. However, the existence of such a 
decarboxylase remains to be proven. Nonetheless, serial oxidation has indeed been suggested 
as a biologically important mechanism for active removal of 5-meC since the final product, 5-
caC, is subjected to excision by thymine DNA glycosylase (TDG) which subsequently 
activates the base excision repair (BER) pathway (He et al., 2011; Maiti and Drohat 2011; 
Hashimoto et al., 2012). Moreover, 5-hmC has also been reported to be more prone to 
AID/APOBEC-mediated deamination than 5-meC, thus suggesting another possible multi-
step mechanism for 5-meC demethylation in which the resulting 5-hydroxymethyluracil (5-
hmU) is also a substrate for TDG (Cortellino et al., 2011; Hashimoto et al., 2012). Although 
the complete mechanism of active 5-meC demethylation is still not known, the present picture 
clearly suggests TET-mediated 5-meC oxidation to 5-hmC to be the first step. 
The presence of 5-hmC in genomic DNA has proposed this modification to be a 
biologically relevant epigenetic mark rather than simply an intermediate in the 5-meC 
demethylation process (He et al., 2011; Ito et al., 2011; Pfaffeneder et al., 2011). Intriguingly, 
the previously reported decrease of 5-meC in the paternal pronucleus during zygotic 
reprogramming was recently shown to correlate with accumulation of 5-hmC, while the 
maternal pronucleus exhibited low 5-hmC and high 5-meC levels (Gu et al., 2011; Iqbal et al., 
2011; Wossidlo et al., 2011). This conversion of 5-meC to 5-hmC was further shown to be 
catalyzed by TET3 (Gu et al., 2011). Notably, however, the paternal genome levels of 5-hmC 
have also been reported to be subjected to passive dilution upon replication (Inoue et al., 
2011; Inoue and Zhang 2011). Moreover, it remains to be determined whether 5-hmC is 
recognized by reader proteins equivalent to the 5-meC binding MBPs. Clearly, additional 
effort is needed to determine the precise role of 5-hmC and its oxidation products in 5-meC 
demethylation as well as in the processes of chromatin regulation and epigenetic 
reprogramming. 
Histone modifications 
DNA is not the only chromatin component subjected to modifications. The N-terminal 
tails of the core histones, which protrude from the nucleosomes and are consequently 
available to modifying enzymes, display a wide variety of covalently linked chemical groups 
such as acetyl, methyl and phosphate (reviewed in Bannister and Kouzarides (2011)). The 
different modifications are introduced at the side chains of specific amino acid residues, 





Figure 5. Oxidative reactions by chromatin-targeting Fe(II)/2OG-dependent dioxygenases. 
A) TET protein-mediated hydroxylation of 5-meC in DNA to 5-hmC. In presence of ATP the product 
can be further oxidized to the stable modifications 5-fC and 5-caC. B) JmjC-domain containing 
proteins catalyze demethylation of methyl-lysine in histones through hydroxylation of the methyl 
group(s), which is/are spontaneously released as formaldehyde (HCHO). Adapted from Loenarz and 
Schofield (2011) and Tan and Shi (2012). 
histone acetyl- and methyltransferases (HATs and HMTs) as well as kinases, and the effects 
depend on the specific chemical group. Methylation differs from acetylation and 
phosphorylation in the way that the target arginine and lysine residues are not limited to 
modification with a single methyl group, but can acquire higher order methylation levels. 
While arginines can be dimethylated, either symmetrically or asymmetrically, lysines display 
the potential of both di- and trimethylation in addition to mono-methylation (reviewed in 
Bedford and Clarke (2009); Lan and Shi (2009)). 
Generally, acetylation is associated with an open chromatin state as the positive charge 
of the affected lysine side chains are neutralized, leading to chromatin decondensation 
through decreased affinity of histones for DNA (Bannister and Kouzarides 2011). In a similar 
fashion, phosphorylation also provides increased chromatin access as addition of negative 
phosphate groups to serine residues result in a weakened histone-DNA interaction. In 
contrast, methylation does not influence on this electrostatic aspect of chromatin regulation as 
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the small, neutral methyl group does not alter histone charge and hence does not cause direct 
chromatin structure perturbation. 
A second mechanism by which histone modifications regulate chromatin structure is 
by providing binding sites for effector proteins which function in ATP-dependent structure 
remodeling or recruitment of additional modification enzymes. Among the proteins that are 
recruited to methyl groups are the chromodomain and Tudor domain containing proteins and,  
similarly, acetyl and phosphate groups are recognized by effector protein modules such as 
bromodomains and 14-3-3 domains, respectively (reviewed in Yap and Zhou (2010)). 
Notably, certain modifications can also prevent binding of effector proteins (Fischle et al., 
2005; Iberg et al., 2008). By such indirect means, the modification-embedded information in 
the histones can be interpreted by chromatin effectors whose action further modulate the 
chromatin structure positively or negatively to bring about the biological outcome. 
Several modifications occur in close proximity on the histone tails, suggesting that the 
binding ability of an effector protein to its target will also be influenced by the modifications 
on neighboring residues. According to the “histone code” hypothesis, the different histone tail 
modifications act together, thus increasing the complexity of the regulatory system provided 
by histone modifications (Strahl and Allis 2000). This provides another dimension to the 
aspect of chromatin regulation mediated through post-translational histone marks, and 
increasing evidence for the existence of combinatorial effects of histone modifications is 
currently emerging (reviewed in Rando (2012)), as several effector proteins have been 
reported to possess binding modules that recognize a modification only in a certain context. 
Completing the circle of histone modification regulation, enzymes with the ability to 
catalyze histone mark removal, like histone deacetylases (HDACs), demethylases (HDMs) 
and phosphatases, exist to counteract the activity of those introducing the modifications 
(reviewed in Bannister and Kouzarides (2011)). Thus, the antagonistic actions of histone code 
writers and erasers thus function to control chromatin structure dynamics in order to regulate 
transcription and other chromatin-dependent processes such as replication and DNA repair. 
Histone methylation reversal 
In contrast to other histone modifications, methylation was considered a static and 
irreversible mark as no enzyme with histone demethylase activity was known. Nearly a 
decade ago, this view was radically changed with the identification of lysine-specific 
demethylase 1 (LSD1), an amine oxidase with the ability to catalyze reversal of lysine 
methylation (Shi et al., 2004). However, this chemical mechanism requires two unpaired 
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electrons in the nitrogen on which the methyl groups are situated, thus restricting the LSD1 
activity to mono- and di-methylated lysines (Shi et al., 2004). 
Interestingly, histone lysine demethylase activity was demonstrated also for a 
subgroup of the Jumonji C (JmjC) domain-containing enzymes, referred to as the JmjC 
domain-containg histone demethylases (JHDMs) (Cloos et al., 2006; Fodor et al., 2006; Klose 
et al., 2006; Tsukada et al., 2006; Whetstine et al., 2006; Yamane et al., 2006; Hong et al., 
2007; Qi et al., 2010). Belonging to the superfamily of Fe(II)/2OG-dependent dioxygenases, 
the JmjC proteins employ the same demethylation mechanism used by AlkB to repair 
methylation damage in nucleic acids, i. e. hydroxylation of the histone lysine methyl group 
which is consequently destabilized and spontaneously released as formaldehyde (Tsukada et 
al., 2006). This reaction mechanism is, in contrast to that of the LSD1 family, compatible with 
reversal of mono-, di- and trimethyl-lysine (Figure 5B). However, as described in more detail 
below, the initially reported histone lysine and arginine demethylase activities of the JmjC-
domain enzymes Jmjd5 and Jmjd6, respectively, have subsequently been challenged. 
The mammalian ALKBH family might also be involved in histone demethylation, as 
ALKBH1 has been proposed to regulate gene expression through its histone H2A 
dioxygenase activity (Lando et al., 2012; Ougland et al., 2012). Moreover, the 
Schizosaccharomyces pombe (S. pombe) AlkB family member Ofd2, which is highly similar 
to ALKBH1, was reported to regulate the expression of oxidative phosphorylation genes 
during hypoxia through oxidation of histone H2A (Lando et al., 2012). However, this activity 
was suggested to result in H2A hydroxylation, not demethylation (Lando et al., 2012). 
Evidently, the dynamics of histone methylation are not yet fully understood. The 
present picture of its regulation leaves lysine 79 in histone H3 (H3K79) as the only known 
methylation-subjected histone lysine residue for which no demethylase has been identified 
(Lan and Shi 2009; Liu et al., 2010; Qi et al., 2010; Stender et al., 2012). Furthermore, the 
debate concerning the existence of direct methyl-arginine reversal persists, as the only 
enzyme known to antagonize the action of the methyl-arginine generating protein arginine 
methyltransferases (PRMTs), peptidyl arginine deiminase 4 (PADI4), converts methyl-
arginine to the non-standard amino acid citrulline through deimination, rather than catalyzing 
its demethylation to arginine (Cuthbert et al., 2004; Wang et al., 2004). However, the 
mechanism used by Fe(II)/2OG-dependent dioxygenases could easily be imagined to catalyze 
reversal of methylarginine as well as methylated H3K79. Hence, if such enzyme activities 




Gene regulation by Fe(II)/2OG-dependent dioxygenases also involves protein 
hydroxylation. An example of such a hydroxylated protein is the transcription factor hypoxia-
inducible factor (HIF), which functions to stimulate gene expression through binding to 
hypoxia response elements (HREs) in the promoters of a set of genes involved in the cellular 
response to hypoxia (Semenza 1999; Kaelin and Ratcliffe 2008). HIF is composed of two 
subunits, HIF-1Į and HIF-1ȕ which upon hypoxia dimerize to induce transcription of target 
genes (Wang and Semenza 1995). However, under normoxic conditions HIF-1Į is negatively 
regulated by two pathways which both involve the activity of Fe(II)/2OG-dependent 
dioxygenases, thereby inhibiting target gene expression. Engaged in the first pathway is the 
asparaginyl hydroxylase factor inhibiting HIF (FIH), which through hydroxylation of Asn803 
in the C-terminal transactivation domain of HIF-1Į represses the transcriptional activity of 
HIF by preventing recruitment of the co-activator p300 (Lando et al., 2002). The other 
pathway involves prolyl hydroxylase domain protein (PHD)-mediated hydroxylation of two 
proline residues (Pro402 and Pro564) in HIF-1Į, leading to its ubiquitination and proteasomal 
degradation (Ivan et al., 2001; Jaakkola et al., 2001). 
Another transcription factor, nuclear factor of activated T-cells calcineurin-dependent 
1 (NFATc1), was recently reported to be regulated through lysine hydroxylation by the JmjC-
domain containing enzyme Jmjd5 (Youn et al., 2012). The previously reported histone lysine 
demethylase activity (Hsia et al., 2010) was not detected, suggesting protein hydroxylation as 
the biologically relevant Jmjd5 activity. Similarly, Jmjd6, initially identified as the first 
histone arginine demethylase (Chang et al., 2007), was later found to not target histone 
methyl-arginine, but rather possess lysine hydroxylase activity towards the RNA splicing 
factor U2AF65 (Webby et al., 2009). Supporting the suggested functions of Jmjd5 and Jmjd6 
in protein hydroxylation, these proteins were on the basis of structural studies shown to be 
homologous to the asparaginyl hydroxylase FIH (Elkins et al., 2003; Del Rizzo et al., 2012). 
RNA modifications 
Traditionally, post-transcriptional RNA modifications were viewed to play a role in 
fine-tuning of RNA structure and function (Bokar 2005). However, following the discovery 
that some of these modifications are reversible (Yi and Pan 2011), it was suggested that RNA 
modifications might function in regulation of gene expression, analogous to the dynamic 
methylations found in DNA and histones (He 2010). One of the well-known RNA 
modifications recently found to be reversible, N6-methyladenosine (6-meA) in mRNA, has 
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previously been proposed to affect translation efficiency, since the methylated dihydrofolate 
reductase (DHFR) transcript was found to be translated more efficiently than the non-
methylated one (Tuck et al., 1999). Further supporting a gene regulatory role of 6-meA and 
FTO, the Fe(II)/2OG-dependent dioxygenase responsible for its demethylation (Jia et al., 
2011), 6-meA was reported to be important for pre-mRNA splicing (Dominissini et al., 2012). 
Very recently, a second Fe(II)/2OG-dependent dioxygenase, ALKBH5, was demonstrated to 
reverse 6-meA in mRNA (Zheng et al., 2012). ALKBH5 demethylase activity was further 
shown to be important for proper mRNA export to the cytoplasm, suggesting that 6-meA 
functions in post-transcriptional regulation of gene expression at the level of mRNA (Zheng et 
al., 2012). In addition, another RNA modification, mchm5U, which is introduced in the 
anticodon-loop wobble position of tRNAGly by ALKBH8-mediated hydroxylation of mcm5U 
(Fu et al., 2010; van den Born et al., 2011), has also been speculated to function in gene 
regulation since the modification alters the affinity of tRNA to specific mRNA codons (Fu et 
al., 2010). 
Finally, structural studies of Jmjd6 suggested ssRNA, but not ssDNA or double-
stranded nucleic acids, to be a biologically relevant substrate of this enzyme (Hong et al., 
2010). Whether this RNA binding is related to the catalytic activity of Jmjd6 remains to be 
established. However, given the previously shown association with the mRNA splicing factor 
U2AF65 (Webby et al., 2009), Jmjd6 was further proposed to possibly function in regulation 
of alternative splicing through pre-mRNA demethylation or hydroxylation (Hong et al., 
2010). 
Thus, post-transcriptional regulation of gene expression at the level of RNA appears to 




Aim of study 
The E. coli AlkB protein is a Fe(II) and 2-oxoglutarate-dependent DNA repair enzyme 
involved in reversal of alkylation damage (Aravind and Koonin 2001; Falnes et al., 2002; 
Trewick et al., 2002). Initially, a single human homolog was identified (Wei et al., 1996). 
However, two subsequent studies revealed, through bioinformatics, the presence of six 
additional homologs (Kurowski et al., 2003; Gerken et al., 2007), and to date this protein 
family comprises nine proteins, ALKBH1-8 and the fat mass and obesity-related protein 
(FTO). While ALKBH2 and ALKBH3 were shown to possess similar functions as AlkB 
relatively soon after their discovery (Aas et al., 2003), the functions of the remaining ALKBH 
proteins have just recently started to emerge. Initially, the large number of homologs led to 
the correct suggestion that some of them does not function in DNA repair.  
The aim of this study has been to improve our knowledge on the functions of 
uncharacterized members of this mammalian protein family. While the main focus has been 
characterization of ALKBH4, we have also touched upon ALKBH7. The initial approach 
chosen to investigate the functions of these proteins involved Yeast two-hybrid screens to 
identify interaction partners and, thereby, biological processes in which these proteins are 
involved (Paper II). Moreover, based on our finding that ALKBH4 possesses a unique 
cysteine-rich cluster in the N-terminus (Paper I), we aimed at obtaining insights into the iron-
binding properties of ALKBH4. This issue was addressed through site-directed mutagenesis 
of residues in the cysteine cluster, as well as in the previously predicted active site iron-
binding motif, and subsequent spectroscopic studies and measurements of the in vitro enzyme 
activity of the recombinant proteins. 
Although the activities of some mammalian ALKBH proteins have been disclosed 
during the time period of this study, the biological function of several of these enzymes, 
including ALKBH4 and ALKBH7, still remains to be revealed. The work underlying this 
thesis is thus part of the continuing project with the objective of elucidating the functions of 







Summary of papers 
Paper I 
Spectroscopic and magnetic studies of wild-type and mutant forms of the Fe(II)- and 2-
oxoglutarate-dependent decarboxylase ALKBH4 
Bjørnstad L. G., Zoppellaro G., Tomter A. B., Falnes P. Ø. and Andersson K. K. 
Biochem. J. (2011) 434, 391-398 
In this first report on ALKBH4, we describe the spectroscopic properties of the 
predicted iron-binding motif in the active site of this protein through electron paramagnetic 
resonance (EPR) and ultraviolet-visible (UV-vis) spectroscopy. Site-directed mutagenesis of 
the two proximal residues in the HXD…H (H169A-D171A-H254) triad predicted to bind iron 
confirmed this motif to indeed be essential for iron coordination. 
In addition, we reported the presence of a unique conserved motif comprising four 
cysteine residues in the N-terminus of putative ALKBH4 orthologs. However, our speculation 
of whether this motif composes an iron-sulfur cluster was not supported as abrogation of the 
cysteine cluster did not affect the iron-binding features of ALKBH4, suggesting that 
ALKBH4 is a mononuclear iron protein.  
Finally, we demonstrated that recombinant ALKBH4 is able to perform 
decarboxylation of the co-substrate 2-oxoglutarate (2OG) in absence of primary substrate, an 
uncoupled reaction typical for Fe(II)/2OG-dependent dioxygenases. Consistent with the 
results obtained from the spectroscopic analysis, both ferrous iron (Fe(II)) and an intact iron-
binding site, were required for such activity, while the cysteine motif was not. In conclusion, 
we provided experimental data supporting that ALKBH4 is an active enzyme and a bona fide 
member of the superfamily of Fe(II)/2-OG-dependent dioxygenases. 
Paper II 
Human ALKBH4 interacts with proteins associated with transcription 
Bjørnstad L. G., Meza T. J., Otterlei M., Olafsrud S. M.,  Meza-Zepeda L. A. and Falnes P. Ø. 
PLoS ONE (2012) 7(11): e490945. doi:10.1371/journal.pone.0049045 
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This study focused on increasing our knowledge about the functions of ALKBH4 and 
the non-characterized paralog ALKBH7. In order to identify biological processes in which the 
two proteins exert their functions, we searched for interaction partners of the two proteins 
through yeast two-hybrid screens. While this approach did not reveal any binding partners for 
ALKBH7, we found ALKBH4 to interact with several proteins associated with transcription. 
Furthermore, these interactions were all indicated to be mediated through chromatin-
associated domains, suggesting involvement of ALKBH4 in chromatin regulation. Moreover, 
the interactions were not dependent on the enzymatic activity of ALKBH4. 
Supporting the results from the yeast two-hybrid analysis, three of the transcription-
associated proteins showed nuclear co-localization with ALKBH4 in nucleoplasm and 
nucleoli. Interestingly, we also noted these proteins to exist as fusion partners of the histone 
methyltransferase MLL in the acute leukemia subtype mixed-lineage leukemia. 
Furthermore, to address the possible effect of ALKBH4 and ALKBH7 on 
transcriptional regulation, we performed a comparison of the gene expression profiles of cells 
over-expressing ALKBH4 or ALKBH7 with those of the respective non-overexpressing cells. 
While ALKBH4 over-expression had a remarkably small effect on the global gene expression 
pattern, indicating no role in transcription regulation at the genome-wide level, over-
expression of ALKBH7 resulted in larger perturbations in the gene expression pattern. Gene 
ontology (GO) analysis of the genes affected by ectopic ALKBH7 expression revealed 
enrichment of genes involved in processes such as cell cycle regulation, DNA damage and 
spermatogenesis. Consistent with this, we found three genes associated with meiotic 
recombination among the twenty most up-regulated genes. Additionally, a CpG methylation 
profile analysis excluded involvement of both proteins in regulation of global CpG 
methylation levels. 
Taken together, the results obtained in this study suggest some processes in which 
ALKBH4 and ALKBH7 might function and provide a base for further investigation of the 




The DNA repair enzyme AlkB from E. coli is a Fe(II)/2OG-dependent dioxygenase 
for which nine mammalian homologs, ALKBH1-8 and FTO, have been identified through 
bioinformatics. The study underlying this thesis has contributed to increased insight into the 
functions of two uncharacterized human ALKBH proteins, ALKBH4 and ALKBH7. When 
this study was initiated, the biological function of only one of the mammalian proteins, the 
functional AlkB homolog ALKBH2, had been established, and it has proven difficult to 
elucidate the roles of the remaining family members. However, their functions have started to 
slowly emerge, revealing involvement in other cellular pathways, as was proposed already a 
decade ago. Our findings indicate that both ALKBH4 and ALKBH7 are likely involved in 
processes other than repair of alkylation lesions in nucleic acids and provide a basis for 
further research aiming to disclose the functions of these interesting enzymes. 
Biological function of ALKBH4 
ALKBH4 in gene regulation – transcription and chromatin 
In an attempt to increase our knowledge on the biological function of ALKBH4, we 
used the yeast two-hybrid (Y2H) system to identify interaction partners (Paper II). Several of 
its putative partners are associated with transcriptional regulation, suggesting ALKBH4 to be 
involved in regulation of gene expression. As the regions found to mediate binding to 
ALKBH4 in all cases comprised chromatin-binding domains, regulation by ALKBH4 may 
occur at the chromatin level.  
Two of the ALKBH4-interacting proteins identified in the Y2H system, the related 
proteins AF9 and ENL, are components of the super elongation complex (SEC) (Lin et al., 
2010; Mohan et al., 2010; He et al., 2011), which regulates the elongation step of transcription 
(references in Smith et al. (2011)). SEC recruitment to chromatin-bound RNA Polymerase II 
occurs via the AF9/ENL YEATS domain to sequence-specific factors such as mixed-lineage 
leukemia (MLL) (Yokoyama et al., 2010), or to the general Polymerase-associated factor 
complex (PAFc) (He et al., 2011). The region of AF9/ENL required for the interaction with 
ALKBH4 was the YEATS domain. Further supporting this, ALKBH4 co-localized with the 
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ENL YEATS domain in HeLa cells, while a YEATS domain truncation of ENL did not 
(Paper II). Thus, ALKBH4 might function in regulation of SEC recruitment to target sites. 
Furthermore, the transcriptional co-activator and histone acetyl transferase (HAT) 
p300, here found to interact with ALKBH4 (Paper II), interacts with the non-phosphorylated, 
transcription initiation-associated form of RNA polymerase II (Cho et al., 1998). The p300 
region responsible for the interaction to ALKBH4, the bromodomain (BRD) and plant 
homeodomain (PHD), has been demonstrated to function in recruitment of the protein to 
acetylated nucleosomes (Ragvin et al., 2004). 
Moreover, we detected the heat-shock transcription factor HSF4 to interact with 
ALKBH4 through its DNA binding domain (DBD) (Paper II). Supporting this interaction, 
HSF4 targets the Hsp70-encoding HSPA1 gene (Tu et al., 2006), which was upregulated upon 
ALKBH4 over-expression (Paper II). Moreover, HSPA8, the gene encoding the constitutively 
expressed heat-shock protein Hsc70, was also upregulated. This further strengthens the 
suggested involvement of ALKBH4 in regulation of transcription elongation, since SEC 
components were previously reported to localize to HSPA1 upon heat-shock (Lin et al., 2010). 
In conclusion, our findings suggest that ALKBH4 functions in gene regulation at the 
level of transcription, possibly by regulating recruitment of transcription complexes to 
chromatin target sites. However, it remains to be determined whether ALKBH4 affects 
transcription in a positive or negative manner, and the molecular mechanism for the suggested 
regulatory function of ALKBH4 also requires further investigation. 
ALKBH4 is not involved in regulation of 5-methylcytosine 
Transcriptionally repressed genes are generally associated with presence of 5-
methylcytosine (5-meC) in their promoters. The chemical mechanism by which AlkB, 
ALKBH2 and ALKBH3 reverse nucleic acid alkylation damage could be envisioned to be 
utilized for oxidation of a methyl group in the 5-position of cytosine, and hydroxylation of 5-
meC was proposed as a potential function for uncharacterized mammalian AlkB homologs 
(Sedgwick et al., 2007). When this study was initiated, it had not yet been shown that 5-meC 
hydroxylation is actually the reaction catalyzed by the TET proteins. We thus speculated 
whether ALKBH4, being an Fe(II)/2OG-dependent dioxygenase potentially involved in 
regulation of transcription, could possess similar activity. However, consistent with the 
subsequent identification of TET1-mediated conversion of 5-meC to 5-
hydroxymethylcytosine (5-hmC) (Tahiliani et al., 2009), we observed no effect on the global 
5-meC pattern upon over-expression of ALKBH4 (Paper II).  
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Mixed-lineage leukemia – a role for ALKBH4? 
Mixed-lineage leukemia (MLL) is a particularly aggressive subtype of acute leukemia 
which is associated with chromosomal translocations involving the MLL gene. MLL is a 
histone methyltransferase with specificity for lysine 4 in histone H3 (H3K4) (Milne et al., 
2002). However, leukemic rearrangements result in chimeric proteins in which the N-terminal 
of MLL is fused in-frame to the C-terminal part of the fusion partner, and loss of H3K4 
methyltransferase activity. A large number of translocation partners has been reported (Meyer 
et al., 2009), and their structural and functional diversity has contributed to confusion with 
respect to the molecular mechanism by which the MLL-fusions cause leukemia. MLL 
leukemias generally display aberrant H3K79 dimethylation profiles and dysregulated Hox 
gene expression (Armstrong et al., 2002; Ferrando et al., 2003; Krivtsov et al., 2008). Hence, 
the underlying mechanism for transformation was believed to occur through misrecruitment 
of the H3K79 methyltransferase DOT1L to MLL target genes by the fusion partner.  
However, recent biochemical studies revealed that the most common fusion partners together 
exist in the SEC (Lin et al., 2010; Yokoyama et al., 2010). The predominant mechanism for 
MLL-fusion mediated leukemogenesis was therefore suggested to be constitutive recruitment 
of SEC, rather than DOT1L, to MLL target genes, resulting in their aberrant activation 
through circumvention of the transcriptional initiation-to-elongation checkpoint (Mohan et al., 
2010). The biological significance of increased H3K79 methylation in leukemic cells is still 
not clear, although the DOT1L complex is essential for transformation (Nguyen et al., 2011). 
Intriguingly, three of the ALKBH4 partners identified in this study, AF9, ENL and 
p300 (Paper II), are fused to MLL in leukemia (Iida et al., 1993; Rubnitz et al., 1994; Ida et 
al., 1997). Both AF9 and ENL interact with DOT1L and SEC in a mutually exclusive manner 
(Lin et al., 2010; Yokoyama et al., 2010; Biswas et al., 2011; He et al., 2011), and the 
corresponding MLL-fusions are associated with constitutive recruitment of SEC and DOT1L 
to MLL target genes, suggesting that the resulting leukemic transformation is caused by 
persistent RNA Polymerase II-mediated gene transcription and H3K79 hypermethylation 
(Figure 6A) (Yokoyama et al., 2010; Bernt et al., 2011; Biswas et al., 2011). In contrast, the 
less frequent MLL-p300/CBP fusions are thought to promote leukemogenesis through 
aberrant histone acetylation, since the fusion proteins retain the histone acetyl transferase 
(HAT) domain (Figure 6B) (Ida et al., 1997; Slany 2009). The use of different mechanisms by 
MLL-AF9/ENL and MLL-p300 fusion proteins makes it difficult to suggest a specific role for 
ALKBH4 in MLL-based transformation. Direct participation of ALKBH4 in MLL-p300 
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mediated leukemogenesis could readily be imagined since the region of p300 necessary and 
sufficient for leukemic transformation comprises, in addition to the HAT domain, the 
bromodomain (BRD) and the PHD finger (Ida et al., 1997), both of which we found to be 
involved in mediating the interaction with ALKBH4 (Paper II). However, the ALKBH4-
interacting YEATS domain is typically not present in the fusion proteins MLL-AF9 and 
MLL-ENL (Rubnitz et al., 1994), suggesting that ALKBH4 may be indirectly linked to 
leukemogenesis through its impaired recruitment to AF9/ENL. Alternatively, since the 
physiological SEC and DOT1L complexes are both required for leukemogenesis (Yokoyama 
et al., 2010; Nguyen et al., 2011), a direct role of ALKBH4 in the transformation process 





Figure 6. Schematic representation of the proposed mechanisms for leukemogenesis by the 
MLL-fusion proteins A) MLL-AF9/ENL and B) MLL-p300/CBP. In all cases, the N-terminal part of 
MLL (MLLN) remains unchanged and retains its interaction with the chromatin-targeting factors Menin 
and lens-epithelium derived growth factor (LEDGF). However, the C-terminal part, including the SET 
methyltransferase domain, is exchanged with the fusion partner which is believed to be actively 
involved in leukemic transformation. MLL-AF9/ENL fusions are thought to promote leukemogenesis 
through stimulation of transcriptional elongation via the two elongation factors positive transcription 
elongation factor b (pTEFb) and eleven-nineteen lysine-rich leukemia (ELL), which both are 
components of the super elongation complex (SEC). Histone methylation by another AF9/ENL partner, 
the histone H3K79 methyltransferase DOT1L, is also associated with leukemic transformation. The 
mechanism used by MLL-p300/CBP fusions, which retain the histone acetyltransferase (HAT) activity 




ALKBH4 in development 
Gene targeting studies in mice have shown that both Af9 and Enl function in 
embryonic development (Collins et al., 2002; Doty et al., 2002). While Enl-inactivation leads 
to early embryonic lethality in mice (Doty et al., 2002), disruption of Af9 is associated with 
perinatal lethality and altered expression of Hox genes, consistent with a function for AF9 in 
embryo patterning and antero-posterior axis formation (Collins et al., 2002). Initial Hox gene 
activation involves fibroblast growth factors (FGFs), and establishment of Hox expression 
patterns are dependent on retinoic acid (RA) signaling (reviewed in Deschamps et al. (1999)). 
Subsequently, the Hox expression domains established along the primary body axis are 
maintained by Trithorax and Polycomb group (TrxG and PcG) proteins which regulate the 
chromatin structure of the Hox gene cluster in a positive and negative manner, respectively 
(Gould 1997; Deschamps et al., 1999). Further supporting a role for AF9/ENL in regulation 
of Hox gene expression, both proteins have been reported to interact with the human PcG 
protein hPc3 (Garcia-Cuellar et al., 2001; Hemenway et al., 2001). Functions consistent with 
embryo patterning have also been reported for other herein-identified ALKBH4 partners. The 
homeotic transcription factor ATBF1 is expressed upon RA-induced neuronal differentiation 
(Ido et al., 1994) and HSF4 controls FGF repression during lens cell differentiation (Fujimoto 
et al., 2004). Likewise, the Xenopus ortholog of the non-transcription-associated ALKBH4 
partner TES has also been implicated in regulation of axial elongation through FGF signaling 
(Dingwell and Smith 2006). Furthermore, studies in mice have shown that p300 is essential 
for embryogenesis (Yao et al., 1998), during which it is normally involved in neural tube and 
craniofacial development (Bhattacherjee et al., 2009). Notably, Alkbh4-targeted mice are early 
embryonic lethal (Nilsen and Klungland, unpublished data), demonstrating an essential 
developmental function also of ALKBH4. Taken together, this putative developmental 
function of ALKBH4 might possibly manifest through regulation of genes involved in 
developmental axis formation. 
Biochemical function of ALKBH4 
The biochemical functions of several mammalian ALKBH proteins, including 
ALKBH4, have not yet been determined. However, a previous study demonstrated that 
ALKBH4 is not engaged in DNA repair through demethylation of 1-meA or 3-meC, since the 
protein neither complemented the sensitivity of an AlkB-deficient E. coli strain towards 
transformation of MMS-treated single-stranded M13mp18 bacteriophage DNA, nor displayed 
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in vitro activity towards single- or double-stranded oligodeoxyribonucleotide substrates 
containing 1-meA or 3-meC (Bekkelund and Falnes, unpublished data; Lee et al. (2005)). The 
initial classification of ALKBH4 as a member of the mammalian AlkB family was based on a 
bioinformatics study (Kurowski et al., 2003), and has not been experimentally confirmed. 
Here we show, through spectroscopic studies, that ALKBH4 exhibits similar features as AlkB 
with respect to Fe(II) binding (Paper I), supporting the prediction of ALKBH4 being a 
member of the AlkB family of Fe(II)/2OG-dependent dioxygenases. Further supporting this, 
we demonstrated that ALKBH4 in presence of Fe(II) is able to decarboxylate 2-oxoglutarate, 
resulting in formation of succinate (Paper I), thus strongly suggesting that ALKBH4 has 
enzymatic oxygenase activity. 
Hence, as an Fe(II)/2OG-dependent enzyme, ALKBH4 presumably catalyzes 
hydroxylation or demethylation of a yet unidentified protein or nucleic acid substrate, an issue 
that will be discussed in closer detail below. 
Hydroxylase or demethylase activity? 
Fe(II)/2OG-dependent dioxygenases typically catalyze hydroxylation reactions. While 
plants and microorganisms possess Fe(II)/2OG dioxygenases which catalyze oxidative 
reactions apart from the prevalent hydroxylations (Valegard et al., 1998; Turnbull et al., 2004; 
Vaillancourt et al., 2005), only hydroxylations have been reported for these enzymes in 
animals. As the first family member, E. coli AlkB was demonstrated to possess demethylase 
activity, in which methylation reversal occurs through hydroxylation of the target methyl 
group (Falnes et al., 2002; Trewick et al., 2002). Similarly, most of the characterized 
mammalian ALKBH proteins catalyze substrate demethylation via hydroxylation (Aas et al., 
2003; Jia et al., 2011), however, conventional substrate hydroxylation is also represented 
among the ALKBHs, as target hydroxyl modification is performed by the oxygenase domain 
of ALKBH8 (Fu et al., 2010; van den Born et al., 2011). Thus, ALKBH4 probably possesses 
hydroxylase or hydroxylation-mediated demethylase activity. 
Auto-hydroxylation of ALKBH4? 
Spectroscopic studies have indicated several Fe(II)/2OG-dependent dioxygenases, 
including TfdA (Liu et al., 2001), TauD (Ryle et al., 2003), FIH (Chen et al., 2008) as well as 
AlkB (Henshaw et al., 2004), to catalyze auto-hydroxylation of an active-site aromatic residue 
in absence of primary substrate. Such activity involves oxidative conversion of the ferrous 
(Fe(II)) iron to the ferric (Fe(III)) species which complexes with the hydroxylated side chain, 
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resulting in enzyme inactivation. Although the role of self-hydroxylation is unclear, the auto-
hydroxylated forms of both TauD and AlkB have been detected in vivo (Henshaw et al., 2004; 
Grzyska et al., 2007), thus suggesting biological relevance. A proposed function is regulation 
of enzyme activity, possibly to protect against formation of deleterious oxygen radicals in 
absence of substrate (Liu et al., 2001; Hausinger 2004) or, in the case of FIH, to regulate the 
hypoxia response (Chen et al., 2008). Self-hydroxylation of an active site residue has also 
been observed for ALKBH3, however, in contrast to the previously reported cases, the target 
site was a leucine rather than an aromatic residue (Sundheim et al., 2006). Notably, 
corresponding oxidation was also detected in all the AlkB family proteins in which this 
leucine is conserved, ALKBH2, ALKBH6 and AlkB (Sundheim et al., 2006). 
Upon oxidation of the ALKBH4/Fe(II)/2OG complex we detected an absorption band 
similar to the oxidation products of the corresponding TfdA (Liu et al., 2001) and FIH (Chen 
et al., 2008) complexes, which was reported to arise from hydroxylated Tyr73 and Trp296, 
respectively (Liu et al., 2001; Ryle et al., 2003). However, we observed a similar absorption 
band also in absence of 2OG, suggesting that the complex giving rise to the chromophore of 
oxidized ALKBH4 may not depend on 2OG. Instead, it might possibly origin from 
complexed iron and oxygen. Together with our observation that the uncoupled 2-oxoglutarate 
turnover was substantially lower for ALKBH4 compared to AlkB (Paper I), this may possibly 
suggest that no self-hydroxylation target is present in or close to the active site of ALKBH4. 
However, in presence of the oxygen analog NO, oxidation of the ALKBH4/Fe(II)/2OG 
complex gave rise to an absorption band closely resembling the one of oxidized 
AlkB/Fe(II)/2OG (in absence of NO). While the latter absorption feature of AlkB was 
demonstrated to arise from auto-hydroxylation of Trp178 (Henshaw et al., 2004), Fe-NO 
could possibly be responsible for the chromophore we observed for 
ALKBH4/Fe(II)/2OG/NO. Evidently, additional effort is required to determine whether 
ALKBH4 displays auto-hydroxylase activity. 
Nucleic acid or protein substrate? 
Although both lipids and small molecules have been reported to be oxidized by 
Fe(II)/2OG-dependent dioxygenases, the substrates of these proteins typically comprise 
proteins and nucleic acids (Hausinger 2004). Notably, the ALKBH proteins for which 
substrates have been identified all target nucleic acids: the repair activities of ALKBH2 and 
ALKBH3 are directed towards lesions in DNA and RNA, respectively (Aas et al., 2003; 
Falnes et al., 2004), FTO and ALKBH8 are both involved in post-transcriptional modification 
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of RNA (Jia et al., 2011; van den Born et al., 2011). This implies that DNA or RNA might be 
the substrate also of ALKBH4. Consistent with the predominant location of ALKBH4 in the 
nucleus (Tsujikawa et al., 2007), including nucleolar speckles (Paper II), DNA or nuclear 
RNA such as mRNA or rRNA might represent possible substrates of this protein, as do 
smaller RNA species such as micro RNA (miRNA), small nuclear RNA (snRNA) or small 
nucleolar RNA (snoRNA). 
However, ALKBH4 was previously, together with ALKBH1 and ALKBH7, suggested 
to act on protein substrates because of their low pI-values which could interfere with 
interaction with a nucleic acid substrate (Sedgwick et al., 2007). Possible ALKBH4 protein 
substrates are the interaction partners, which could be subjected to hydroxylation or 
demethylation. However, information in the Phosphosite database (Hornbeck et al., 2012) on 
post-translational protein modifications indicate that none of the ALKBH4 targets are 
hydroxylated and only two, p300 and eukaryotic translation initiation factor 3C (EIF3C), are 
methylated, disfavoring a hypothesis in which the partners are the ALKBH4 substrates. 
The hydroxylase activities of the JmjC-domain containing Fe(II)/2OG-dependent 
dioxygenases target methyl groups on histone lysine side chains, leading to reversal of histone 
methylation by a mechanism analogous to that of AlkB proteins (Tsukada et al., 2006). 
Interestingly, two of the JmjC proteins initially reported to be histone lysine and arginine 
demethylases respectively, Jmjd5 and Jmjd6, possibly function in vivo to hydroxylate non-
histone proteins (Webby et al., 2009; Del Rizzo et al., 2012; Youn et al., 2012), or even 
ssRNA (Hong et al., 2010). Similarly, histone demethylase activity was recently proposed 
also for the AlkB protein family, as ALKBH1 was suggested, as the first member, to 
demethylate one or two C-terminal lysine residues in histone H2A (Ougland et al., 2012). 
This suggests that that the individual Fe(II)/2OG-dependent dioxygenase subfamilies may not 
be restricted to either protein or nucleic acid substrates. 
The over-representation of chromatin-associated proteins among the ALKBH4 
partners identified in this study could imply that ALKBH4 possesses a histone substrate. Two 
findings made us speculate whether ALKBH4 could possibly target lysine 79 in histone H3 
(H3K79), the one methylation-subjected histone lysine residue for which no demethylase has 
been identified: First, ALKBH4 interacts with AF9/ENL, a component of the DOT1L 
methyltransferase complex which is responsible for methylation of H3K79 (Paper II). Second, 
ALKBH4 over-expression resulted in down-regulation of LGALS1 (Paper II), a biomarker of 
MLL-rearranged leukemia whose upregulation correlates with increased H3K79 methylation 
(Juszczynski et al., 2010). However, as we did not observe any effect of ALKBH4 over-
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expression on the global H3K79 methylation status in HEK293 cells (Paper II), the question 
whether H3K79 is an ALKBH4 substrate remains open. The oxidation mechanism employed 
by Fe(II)/2OG-dependent dioxygenases is also compatible with arginine demethylation 
(Chang et al., 2007). As mentioned above, it is debated whether this proposed activity of 
Jmjd6 is biologically relevant, therefore direct reversal of arginine methylation in vivo has 
still to be demonstrated. However, one could imagine ALKBH4, being a Fe(II)/2OG-
dependent dioxygenase, to possess a methylated histone, or non-histone, arginine as substrate. 
Possible function of the ALKBH4 cysteine cluster 
From the alignment of putative ALKBH4 orthologs from different metazoans, we 
observed a conserved motif comprising four cysteine residues in the N-terminus (Paper I). 
The high degree of conservation between species, together with absence of the motif in AlkB 
as well as in ALKBH proteins, implies its importance for ALKBH4 function. Abrogation of 
the cluster through site-directed mutagenesis of the cysteines to alanine had no effect on the 
uncoupled 2-oxoglutarate decarboxylase activity of ALKBH4 (Paper I), suggesting that the 
motif is not required for the basic enzymatic activity of ALKBH4. A BLAST search in the 
NCBI protein sequence database (Altschul et al., 1997), using the conserved cysteine-rich 
motif as input sequence, revealed no similarity to currently annotated domains. However, 
since cysteine-rich protein modules are often involved in metal coordination, the ALKBH4 
cluster can be expected to constitute a metal site. Our spectroscopic analysis demonstrated 
that ALKBH4 contains a mononuclear iron site which comprises the HXD…H motif, 
suggesting that the cysteine motif is not an iron-sulfur (Fe-S) cluster (Paper I). However, it 
should be noted that an elaborate biosynthetic machinery is required for the formation of 
many Fe-S clusters, which therefore cannot assemble spontaneously in vitro upon 
reconstitution with iron (reviewed in Xu and Moller (2011)).  
Zinc finger domains compose another class of metal-coordinating folds, which are 
remarkably diverse both in structure and function, and can bind both nucleic acids and 
proteins, as well as lipids (Laity et al., 2001). Zinc fingers are common in gene regulatory 
proteins and, given the possible role of ALKBH4 in chromatin regulation (Paper II), the N-
terminal cysteine motif could likely represent a zinc-binding site. In support of such a 
hypothesis, parts of the ALKBH4 cysteine motif show similarities with known zinc fingers of 
the classical C2HC- and C2H2-types, like those found in the nucleolar protein pNO40 and the 
transcriptional repressor ZBRK1 (Zheng et al., 2000; Chang et al., 2003). Notably, the zinc 
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fingers of ZBRK1 have been reported to bind DNA (Zheng et al., 2000), suggesting that also 
the ALKBH4 motif might function as a DNA or RNA recognition motif. However, single 
zinc fingers often mediate protein-protein interactions (Matthews and Sunde 2002). Thus, we 
speculated whether the ALKBH4 cysteine cluster is involved in interaction partner binding. 
However, preliminary data show that cysteine motif abrogation does not affect the co-
localization pattern of ALKBH4 and ENL (Otterlei, Bjørnstad and Falnes, unpublished data), 
suggesting that the module might display other functions, possibly substrate binding. 
Alternatively, although less likely, the motif may simply have a structural purpose, like the 
Zn(II) coordinating cysteine cluster separating the methyltransferase and oxygenase domains 
of ALKBH8 (Pastore et al., 2012). 
ALKBH7 – a possible function in DNA double strand break 
repair during meiotic recombination 
In addition to the focus on characterization of ALKBH4, this study has also touched 
upon another ALKBH protein, ALKBH7. The molecular function of ALKBH7 is, like that of 
ALKBH4, unknown. However, the previous NCBI annotation of ALKBH7 as 
spermatogenesis-associated protein 11 (SPATA11) or “spermatogenesis cell proliferation-
related protein” indicates ALKBH7 to function in spermatogenesis. 
Through functional annotation analysis of genes affected by ALKBH7 over-
expression, we identified spermatogenesis as one of the biological pathways enriched with 
differentially expressed genes, which is consistent with involvement of ALKBH7 in this 
process (Paper II). Furthermore, three of the twenty most upregulated genes, the meiosis-
specific recombinase disrupted meiotic cDNA 1 (DMC1) and the regulatory proteins 
decreased sperm survival 1 (DSS1) and male-specific lethal 3-like 1 (MSL3L1), are involved 
in meiotic recombination (Habu et al., 1996; Kojic et al., 2003; Dray et al., 2006; Sharma et 
al., 2010), a central event in spermatogenesis. Meiotic recombination is initiated with 
formation of DNA double-strand breaks (DSBs) induced by the endonuclease SPO11 
(Keeney et al., 1997; Keeney et al., 1999). The strand breaks are resolved through 
homologous recombination repair (HRR) in a programmed cellular response involving 
checkpoint activation, DNA damage signaling and chromatin rearrangements (Fernandez-
Capetillo et al., 2003; Miles et al., 2010). Furthermore, as revealed through studies of mouse 
gametocytes deficient in central components of the meiotic DSB response machinery, such as 
DMC1, unrepaired DSBs result in increased levels of apoptosis (Yoshida et al., 1998). Since 
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“Cell cycle and its regulation” was the pathway in this study that was mostly enriched with 
genes affected by ectopic ALKBH7 levels, followed by the categories “DNA-damage 
response” and “Apoptosis” (Paper II), our findings are consistent with a role for ALKBH7 in 
regulation of the response to meiotic DNA double strand breaks. Further supporting this, 
mouse Alkbh7 expression is highest at the pachytene stage of male meiosis (GEO accesssion 
GDS2390; (Namekawa et al., 2006), the stage at which recombination occurs. 
Notably, ALKBH7 expression is not restricted to testis (Tsujikawa et al., 2007). 
Moreover, most of the meiotic recombination-associated genes that were found to be 
dysregulated upon ALKBH7 over-expression in this study are also involved in general repair 
of DNA double strand breaks (Gudmundsdottir et al., 2004; Kristensen et al., 2010; Sharma et 
al., 2010). Thus, the suggested involvement of ALKBH7 in homologous recombination might 
extend beyond meiosis to also comprise the mitosis-associated, homologous recombination-
mediated, cellular response to double strand breaks.  
Our findings thus support the previous annotation of ALKBH7 as a spermatogenesis-
related protein, and further indicate that ALKBH7 might be involved in regulation of double 
strand break repair by homologous recombination during meiosis. Additional efforts are 
needed to elucidate the precise role of ALKBH7 in this process, and to determine whether its 








The research underlying this thesis has increased our insight into the field of 
mammalian ALKBH proteins and points towards some biological processes in which 
ALKBH4 and ALKBH7 may be involved. However, the molecular functions of both proteins 
remain to be determined. 
In order to elucidate the function of ALKBH4 it would be useful to identify the role of 
the N-terminal cysteine cluster. Efforts should be invested in determination of the metal 
binding abilities of the motif, in particular with respect to zinc ions, and it would also be 
interesting to determine whether it represents a structural or functional fold. Given the 
possibility that ALKBH4 might possess a nucleic acid substrate, it would also be beneficial to 
examine the ability of the protein to bind DNA and RNA, and the possible involvement of the 
cysteine motif in such interaction. 
Furthermore, the role of ALKBH4 in transcription should be addressed more closely. 
In this respect, it is of interest to determine whether the interaction of ALKBH4 with 
AF9/ENL is associated with gene regulation through the super elongation or DOT1L 
complexes. Considering the striking lack of alterations in the global gene expression pattern 
in HEK 293 cells before and after ALKBH4 over-expression, a possible function of ALKBH4 
at a specific developmental stage or in response to a particular stimulus is likely, and should 
be investigated. Moreover, given that ALKBH4 interacts with three MLL fusion partners, it 
would be of interest to address the role of ALKBH4 in MLL leukemia. 
Finally, it would also be interesting to further investigate the possible regulatory 
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Spectroscopic and magnetic studies of wild-type and mutant forms of the
Fe(II)- and 2-oxoglutarate-dependent decarboxylase ALKBH4
Linn G. BJØRNSTAD, Giorgio ZOPPELLARO, Ane B. TOMTER, Pa˚l Ø. FALNES1 and K. Kristoffer ANDERSSON1
Department of Molecular Biosciences, University of Oslo, P.O. Box 1041, Blindern, NO-0316 Oslo, Norway
The Fe(II)/2OG (2-oxoglutarate)-dependent dioxygenase super-
family comprises proteins that couple substrate oxidation to
decarboxylation of 2OG to succinate. A member of this
class of mononuclear non-haem Fe proteins is the Escherichia
coli DNA/RNA repair enzyme AlkB. In the present work,
we describe the magnetic and optical properties of the yet
uncharacterized human ALKBH4 (AlkB homologue). Through
EPR and UV–visible spectroscopy studies, we address the Fe-
binding environment of the proposed catalytic centre of wild-type
ALKBH4 and an Fe(II)-bindingmutant.We could observe a novel
unusual Fe(III) high-spin EPR-active species in the presence of
sulﬁde with a gmax of 8.2. The Fe(II) site was probed with NO.
An intact histidine-carboxylate site is necessary for productive
Fe binding. We also report the presence of a unique cysteine-
rich motif conserved in the N-terminus of ALKBH4 orthologues,
and investigate its possible Fe-binding ability. Furthermore, we
show that recombinant ALKBH4 mediates decarboxylation of
2OG in absence of primary substrate. This activity is dependent
on Fe as well as on residues predicted to be involved in Fe(II)
co-ordination. The present results demonstrate that ALKBH4
represents an active Fe(II)/2OG-dependent decarboxylase and
suggest that the cysteine cluster is involved in processes other
than Fe co-ordination.
Key words: AlkB, AlkB homologue (ALKBH4), EPR, non-haem
Fe, UV–visible spectroscopy.
INTRODUCTION
The superfamily of Fe(II) and 2OG (2-oxoglutarate, also known
as α-ketoglutarate)-dependent dioxygenases (Pfam accession
number PF03171) is the largest known non-haem Fe protein
family able to carry out hydroxylation reactions of unactivated
C–H groups. These enzymes act on a variety of substrates [1,2],
and the reaction occurs by reductive activation of molecular
oxygen coupled with decarboxylation of the co-substrate 2OG to
succinate [3–5].Within the oxidation process through an Fe(IV)O
intermediate, one of the oxygen atoms from O2 is incorporated
into the succinate moiety and the other becomes a hydroxy group
in the product [3–5]. The catalytically active site is formed by a
mononuclear non-haem Fe centre co-ordinated, in general, by
two histidine residues and one carboxylate moiety [6–9]. This
site is responsible for the binding of 2OG as well as dioxygen.
During turnover, the Fe(II) hexa-co-ordinated states change to a
ﬁnal penta-co-ordinated state, with an open oxygen co-ordination
site [6–9], as observed in the three-dimensional structure of the
deacetoxycephalosporin C synthase with Fe(II) and 2OG bound
(PDB code 1RXG), the ﬁrst structurally characterized member of
this family [10]. However, when uncoupled turnover of 2OG takes
place, either in the absence of natural substrates or due to incorrect
orientation of substrates in the active site, decomposition of 2OG
into succinate and CO2 may lead to enzyme deactivation.
The Fe(II)/2OG dioxygenase AlkB from Escherichia coli is
a repair enzyme, which is induced as part of the adaptive
response to alkylation damage. AlkB catalyses demethylation of
1meA (1-methyladenine) and 3meC (3-methylcytosine) in DNA
in a reaction where the methyl group is hydroxylated and then
released as formaldehyde, thereby regenerating the normal base
[11,12]. Additionally, AlkB repairs the structurally analogous
lesions 1meG (1-methylguanine) and 3meT (3-methylthymidine)
and the bulkier exocyclic etheno and ethano adducts [13–17].
Moreover, AlkB also displays activity on methylated RNA [18].
A bioinformatics analysis revealed eight different mammalian
ALKBHs (AlkB homologues), denoted ALKBH1–8 [19], and a
more recent study has demonstrated FTO (fat mass and obesity-
associated protein) [20] to be a functional ALKBH and thus
the ninth member of this family [21]. AlkB-like in vitro repair
activities have been reported for ALKBH1 [22], ALKBH2,
ALKBH3 [23] and FTO [21], but only ALKBH2 has been
convincingly demonstrated to function as a repair enzyme in vivo
[24,25].
Recently, it has become clear that the ALKBH proteins are
involved in processes other than DNA/RNA repair, as ALKBH8
has been demonstrated to be a tRNA modiﬁcation enzyme [26–
28] and ALKBH1 has been implicated in gene regulation [29].
ALKBH4–ALKBH7 remain completely uncharacterized; in fact,
nothing is known about their ability to bind Fe-metal ion, the
nature of the so-formed active site(s) and their optical/magnetic
ﬁngerprints. From the sequence alignment of putative ALKBH4
orthologues from various organisms, we noted the presence of a
cluster of four highly conserved cysteine residues very close to
the N-terminus (Figure 1). This cluster is not present in AlkB,
and we reasoned that it potentially constitutes a complementary
Fe–S binding site. In order to clearly elucidate the nature of the Fe-
metal binding by human ALKBH4 in its anticipated binding triad
of two histidine residues and one carboxylatemotif (His169-Asp171-
His254) (Figure 2) and to address the possible role of the cysteine
cluster as an additional Fe–S centre, in the presentworkwe studied
the enzymatic activities and the optical and magnetic ﬁngerprints
Abbreviations used: ALKBH, AlkB homologue; FTO, fat mass and obesity-associated protein; GST, glutathione transferase; ICP-AEP, inductively coupled
plasma atomic emission spectroscopy; IPNS, isopenicillin N synthase; IPTG, isopropyl β-D-thiogalactopyranoside; MV•+, Methyl Viologen radical cation;
2OG, 2-oxoglutarate; PAH, phenylalanine hydroxylase; 4,5-PCD, protocatechuate 4,5-dioxygenase; TauD, taurine dioxygenase; UV–Vis, UV–visible; ZFS,
zero-ﬁeld splitting.
1 Correspondence may be addressed to either of these authors (email k.k.andersson@imbv.uio.no or pal.falnes@imbv.uio.no).
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Figure 1 Sequence alignment of the N-terminal part of putative ALKBH4 orthologues from different organisms
Arrows indicate the cysteine residues subjected to mutagenesis (C15A/C17A). GenBank® Identiﬁer (gi) numbers of the displayed sequences are as follows: 8923019 (Homo sapiens), 81905645 (Mus
musculus), 68372246 (Danio rerio), 24583140 (Drosophila melanogaster) and 25148697 (Caenorhabditis elegans). The alignment was generated using the MAFFT algorithm [48] and displayed in
Jalview [49].
Figure 2 Close-up view of the catalytic centre of AlkB in the presence of
bound 2OG (PDB code 2FD8) [50]
The amino acid residues that complex the Fe metal are indicated in black (H131, D133, H187).
A water molecule (W) weakly interacting with the Fe ion (Fe–H2O = 2.9 A˚; 1 A˚ = 0.1 nm) is also
shown. The amino acid residues of ALKBH4 thought to form a similar Fe metal-binding triad
(H169, D171, H254) [19] are indicated by boxed magenta labels.
[UV–Vis (UV–visible)/EPR] of the wild-type protein and of
two mutant derivatives. One mutant (C15A/C17A) contained an
abrogated cysteine cluster, whereas the motif putatively involved
in Fe(II) binding was destroyed in the other (H169A/D171A).
MATERIALS AND METHODS
Plasmid construction and site-speciﬁc mutagenesis of ALKBH4
The cDNA encoding human ALKBH4 was ampliﬁed by
PCR and inserted between the NdeI and BamHI sites of the
expression vector pET-28a (Novagen). The QuikChangeTM
Site-Directed Mutagenesis Kit (Stratagene) was used for
generation of ALKBH4 mutants. To generate the pET-H169A/
D171A plasmid, the primers 5′-CTGCCATTGACCCCGC-
CCTGGCCGACGCCTGGCTG-3′ and 5′-CAGCCAGGCGTC-
GGCCAGGGCGGGGTCAATGGCAG-3′ were used, and
the primers 5′-CGAAGTCCTTCGGGAAGCCGGTGCCAA-
GGGCATCCGGACC-3′ and 5′-GGTCCGGATGCCCTTGGC-
ACCGGCTTCCCGAAGGACTTCG-3′ were used for generation
of the plasmid pET-C15A/C17A (underlining indicates mutation
sites). Plasmids encoding GST (glutathione transferase)-tagged
mutants were obtained by subcloning the mutated cDNA
fragments into the vector pGEX-6P-2 (GE Healthcare), resulting
in the plasmids pGEX-H169A/D171A and pGEX-C15A/C17A
respectively (BamHI and EcoRI sites were used for H169A/
D171A, and BamHI and SalI sites were used for C15A/C17A).
All PCR-generated fragments were veriﬁed by DNA sequencing.
Puriﬁcation of ALKBH4 and mutant proteins
Plasmids were transformed into the E. coli strain BL21-
CodonPlus(DE3)-RIPL (Stratagene), and protein expression was
induced by the addition of 0.075–0.1 mM IPTG (isopropyl β-
D-thiogalactopyranoside). Cells were disrupted by French press
treatment [two passages through a standard FRENCH® pressure
cell (Thermo Electron) at a working pressure of 1000 psi
(1 psi= 6.9 kPa)], and proteins were puriﬁed from clariﬁed
lysates using afﬁnity puriﬁcation. For spectroscopic analysis,
ALKBH4 and mutants were expressed as GST-fusion proteins
and puriﬁed using glutathione–Sepharose 4B medium (GE
Healthcare). The GST tag was removed by on-column enzymatic
cleavage using PreScission protease (GE Healthcare), and HiTrap
Desalting columns (GEHealthcare)were used for buffer exchange
(50 mM Hepes, pH 7.0, and 100 mM KCl). His6-tagged AlkB
proteins for decarboxylation assays were puriﬁed using TALON®
Metal Afﬁnity Resin (Clontech). Proteins were analysed by
SDS/4–12% PAGE and subsequent Coomassie Brilliant Blue
staining. The metal content (Fe) in the protein preparations
was probed by ICP-AEP (inductively coupled plasma atomic
emission spectroscopy), with detection at 238.204 nm for the Fe
ion emission line.
Assay for decarboxylation of 2OG to succinate
The reactions were performed as described previously [14].
Brieﬂy, reaction mixtures of 50 μl contained 50 mM Hepes,
pH 7.5, 4 mM ascorbic acid, 160 μM 2OG (10% [5–14C]2OG),
80 μM FeSO4 (when indicated) and His6-tagged ALKBH4
(500 pmol of wild-type or mutants) or E. coli His–AlkB (100
pmol). EDTA (1 mM) was added to samples without FeSO4.
Reactions were incubated at 37 ◦C for 30 min. The amount of
[1–14C]succinate formed was measured by scintillation counting
after precipitation of the remaining 2OG with 2,4-DNPH (2,4-
dinitrophenylhydrazine).
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Metal-reconstitution procedures and spectroscopic measurements
Concentrated (<300 μM) protein solutions were obtained by
centrifugal ﬁlter devices (Microcon YM-10) in 50 mM Hepes,
pH 7.0, and were then made anaerobic in airtight vessels by
several rounds of vacuum treatment and argon exchange using
the Schlenk technique [29a]. The minimum amount (2 mol
per mol of protein) of a freshly prepared anaerobic solution of
Na2S2O4 (5.7 mM in 50 mMHepes, pH 7.0) was then added to the
protein solutions using airtight syringes. Stoichiometric amounts
of Fe(II) ammonium sulfate were added to the protein samples
in a similar way, using anaerobic stocks. In some cases, small
amounts (∼20 μM) of Methyl Viologen were added in order to
monitor that strict anaerobic conditions were maintained within
reconstitution procedures. Anaerobic solutions of 2OG and Na2S
in 50 mM Hepes, pH 7.0, were freshly prepared and added to
the protein samples at a 10-fold excess. These solutions were
transferred to quartz EPR tubes through airtight syringes that
were maintained under argon, and then the tubes were sealed
with Precision Seal® rubber septa (Sigma–Aldrich). Nitric oxide
(NO) gas was added through airtight syringes directly into the
quartz EPR tubes containing the sample protein, or to airtight
1 cm optical path quartz cuvettes. Samples were maintained at
cold temperatures (10 ◦C). Sample oxidation was obtained by
air exposure followed by slow injection of O2 (∼90% purity,
∼5 min). In the experiments employing reconstitution in the
presence of 2OG/Na2S/Na2S2O4, sample oxidation was obtained
by injection of 50 μl of O2-saturated 50 mM Hepes, pH 7.0, into
EPR tubes containing 100 μl of protein sample, followed by fast
quenching in liquid nitrogen. The low-temperature EPR spectra
were acquired on a Bruker Elexsys 560 instrument equipped with
a dual-bandX-resonator (Bruker) and by using a ESR900He-ﬂow
cryostat (Oxford Instruments). UV–Vis spectra were recorded on
a HP 8452A diode-array spectrophotometer (Hewlett Packard).
RESULTS AND DISCUSSION
Decarboxylation activity of ALKBH4 and mutant proteins towards
2OG
Like several of the Fe(II)/2OG dioxygenases, E. coli AlkB
possesses the ability to perform decarboxylation of 2OG to
succinate even in the absence of primary substrate [11,12].
Since the primary substrate of ALKBH4 is still unknown,
we took advantage of such uncoupled co-substrate conversion
to test the in vitro enzymatic activity of ALKBH4. For this
purpose, recombinant His6-tagged ALKBH4 and two mutants
were puriﬁed from E. coli (Figure 3A) and subsequently assayed
for 2OG decarboxylation activity. Indeed, ALKBH4 was able
to catalyse succinate formation in the presence of the co-factor
Fe(II), although not to the same extent as AlkB (Figure 3B).
The decarboxylation activity was reduced to background levels
when Fe(II) was not included, demonstrating the requirement
for Fe, which is indicative of AlkB proteins. Likewise, the
H169A/D171A mutant was devoid of the ability to perform 2OG
turnover. The C15A/C17A mutant displayed a decarboxylation
activity similar to that of the wild-type ALKBH4 protein,
suggesting that the cysteine motif is not involved in Fe(II) co-
ordination. Taken together, these results experimentally conﬁrmed
that ALKBH4 is a Fe(II)/2OG-dependent decarboxylase.
Spectroscopic ﬁngerprints of the Fe catalytic centre of ALKBH4 and
mutant proteins probed by EPR
The electronic/magnetic ﬁngerprints of the native and mutant
proteins were then addressed by low-temperature EPR
Figure 3 2OG decarboxylation activity of ALKBH4
(A) SDS/PAGE (4–12%) analysis of puriﬁed recombinant proteins. Lane 1, ALKBH4; lane 2,
H169A/D171A mutant; and lane 3, C15A/C17A mutant. The molecular mass in kDa is indicated
on the left-hand side. (B) ALKBH4 (500 pmol of wild-type or mutant protein) or AlkB (100 pmol)
was incubated in the presence of [5–14C]2OG and the resulting [14C]succinate formed was
measured by scintillation counting. Fe(II) was added as indicated. Results are means +− S.D. of
duplicate samples. The bold line shows the averaged background value (2500 c.p.m.).
measurements down to cryogenic temperatures. We probed
different conditions where the metal co-ordination environment
of Fe reconstituted ALKBH4, and mutant proteins were analysed
both in the reduced [Fe(II)] and oxidized [Fe(III)] states, as
well as in the presence or absence of 2OG/succinate. The re-
sults are summarized in Table 1. It should be noted that the
isolated proteins (ALKBH4 and mutants), even when kept in
iced-cooled solutions (4 ◦C), aggregated and then precipitated at
concentrations higher than 0.5 mM. The process was accelerated
greatly when an excess (e.g. 5-fold) of dithionite was added to the
solution when anaerobic Fe(II)-reconstitution procedures were
carried out. Nevertheless, low protein concentrations (<0.3 mM)
and a slight excess of Na2S2O4 (approx. twice greater) allowed
efﬁcient reconstitution of the apo-proteins with the Fe(II) metal
ion, hence avoiding precipitation. The puriﬁed ALKBH4 protein,
in the absence of added cofactors, gave rise to an extremely weak
high-spin Fe(III) signal at g≈4.3 (Figure 4A). This resonance
did not increase upon addition of oxidants (e.g. Na2IrCl6). This
agrees with the ICP-AES ﬁndings that indicated the presence
of Fe traces only in the puriﬁed protein. Traces of Cu(II) ion as
an impurity (around g≈2.1) were also detected, with relative
amounts that changed from sample to sample. When ALKBH4
and the C15A/C17A and H169A/D171A mutants were incubated
with stoichiometric amounts of Fe(II) under reducing conditions,
either in the presence or absence of 2OG/succinate, the recorded
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Figure 4 EPR spectroscopy of Fe-reconstituted ALKBH4 and mutant
proteins
X-band EPR spectra of (A) puriﬁed ALKBH4, (B) ALKBH4 after incubation with stoichiometric
amounts of Fe(II), (C) ALKBH4/Fe(II) after addition of NO, (D) the H169A/D171A/Fe(II)
mutant after addition of NO, (E) ALKBH4/Fe(II) after addition of NO in the presence of 2OG,
(F) ALKBH4/Fe(II) after addition of NO in the presence of succinate, (G) the H169A/D171A/Fe(II)
mutant after addition of O2, (H) ALKBH4/Fe(II)/2OG after addition of O2 and (I) ALKBH4/Fe(II)
after addition of O2. Protein concentrations were 180–200 μM in 50 mM Hepes, pH 7.0.
The measurements were performed at T = 8.0 +− 0.5 K (approx. –265◦C) with the following
parameters: frequency, 9.67 GHz; modulation frequency, 100 KHz; modulation amplitude,
0.7 mT; gain, 55 dB; time constant, 81.92 ms; sweep time, 323 s; microwave power, 0.4–0.8
mW. Two scans were accumulated and averaged; cavity quality factor Q = 4300–4600. Note that
in (B) the sharp signal at g = 2.00 arises from MV•+ , which was used as an internal indicator
to probe the attainment of rigorous anaerobic conditions.
low-temperature EPR spectra did not show any Fe-related
signal (Figure 4B). It is important to note that the only resonance
signal emerging in the spectra was always associated with the
presence of MV•+ (Methyl Viologen radical cation) (g = 2.00
in Figure 4B), which was used as an internal indicator to probe
the attainment of rigorous anaerobic conditions. These results
can be interpreted at X-band EPR with either (i) an integer-spin
system having a high-spin Fe(II) state (S = 2, where S is the
ground-state spin) characterized by a large axial ZFS (zero-ﬁeld
splitting) term called δ in EPR or  in MCD (magnetic CD),
as it occurs in many mononuclear non-haem Fe proteins where
such conﬁguration is usually not spectroscopically accessible,
or alternatively (ii) by a low-spin Fe(II) state (S = 0) [1,2,30].
NO has been successfully used as a probe for such centres
[31], since it can convert the S = 2 species into an EPR-active
S = 3/2 species, as observed, for example, in IPNS (isopenicillin
N synthase) [32], in extradiol-cleaving catechol dioxygenases
such as 2,3-CTD (catechol 2,3-dioxygenase) and 4,5-PCD
(protocatechuate 4,5-dioxygenase) [33,34], as well as in non-
haem Fe model complexes [35]. Upon anaerobic addition of
NO to Fe(II)-reconstituted ALKBH4 and C15A/C17A protein
in the absence of 2OG, a strong axial EPR signal centred at
a geff of 3.97 developed (g-tensor components at g1 = 4.08,
g2 = 3.97 and g3 = 2.00), together with a second asymmetric
resonance at g≈2.00 (Figure 4C). The latter signal contained
features characteristic of a small amount of NO radical being
trapped in the frozen matrix solution. Similarly, when anaerobic
reconstitution of the ALKBH4 and C15A/C17A proteins was
carried out with both Fe(II) and a 10-fold excess of 2OG, a strong
axial resonance signal centred at geff = 3.97 developed after
NO addition, being accompanied by a small highly asymmetric
signal around g≈2.00 (Figure 4E). Analogous spurious signals
at g≈2.00 are found in other non-haem Fe proteins, such as
4,5-PCD [36] and IPNS [32]. Therefore in both cases a nearly
axial S = 3/2 Fe(II)–NO adduct formed with the E (rhombic)
versus D (axial) term |E/D|≈0.010.
Similarly, anaerobic reconstitution of the proteins with both
Fe(II) and a 10-fold excess of the product succinate, followed
by addition of NO, led to a single strong resonance signal
around geff = 3.93 that contained a slightly higher degree of
rhombicity (|E/D|≈0.015) (Figure 4F). The H169A/D171A
protein behaved very differently. After being incubated with
Fe(II) under anaerobic conditions, a very strong signal centred
at g≈2 appeared immediately after addition of NO. Only a
very weak resonance around g≈4 could be detected, with small
variations in relative intensities from preparation to preparation.
These ﬁndings conﬁrm that when the histidine-carboxylate Fe-
binding region is abrogated, only a much smaller fraction of Fe
productively forms stable S = 3/2 Fe–NO complexes (Figure 4D).
Upon addition of oxygen, the ALKBH4 protein sample that
contained 2OG (Figure 4H), and also the sample that was deﬁcient
in co-substrate (Figure 4I), displayed formation of strong similar
signals with broad shoulders at geff = 4.26, being accompanied
by the appearance of weak resonances at geff = 9.40. Those
signals originate from transition involving the middle and ground
Kramer’s doublets respectively and are typically found in high-
spin rhombic Fe(III) centres (|E/D|≈0.25). The same resonances
developed in the C15A/C17A mutant upon Fe(II) oxidation.
Similarly, a strong signal formed at geff = 4.28 upon oxidation
of the Fe(II) H169A/D171A mutant (Figure 4G). However, the
presence of broad shoulders like those of the Fe(III) forms of
both ALKBH4 and the C15A/C17A mutant were not detected.
Such EPR resonance can therefore be interpreted as arising from
spurious or non-speciﬁcally bound Fe(III) metal ion. Surprisingly,
addition of oxygen to the metal-reconstituted ALKBH4 and
C15A/C17A proteins in the presence of succinate resulted in
protein precipitation. The reason for this is presently unknown.
Motivated by the possibility that the N-terminal cysteine-rich
motif might provide an Fe–S cluster, we measured the EPR
spectrum of ALKBH4 in the presence of inorganic S and Fe(II).
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Table 1 X-band EPR data obtained at T = 8.0+− 0.5 K for ALKBH4 and mutant proteins (H169A/D171A and C15A/C17A), in their puriﬁed forms, after Fe-metal
reconstitution in the presence or absence of 2OG/succinate and upon interaction with NO
D, axial ZFS term; E , rhombic ZFS term; n.d., not determined; S, electronic spin state associated with the individual paramagnetic centre (in parentheses/square brackets).
Protein Observed EPR g-values |E/D| S Notes
ALKBH4 puriﬁeda,b 4.30 [Fe(III)], 2.10 [Cu(II)] ∼1/3 5/2 [Fe(III)], 1/2 [Cu(II)] Fe(III) and Cu(II) traces
ALKBH4/Fe(II)a,b 2.00 n.d. 2 [Fe(II)], 1/2 (MV•+) Recorded under reducing conditions (Na2S2O4) in the presence of
MV•+ . Fe(II) was not EPR-visible at X-band; MV•+ was EPR
active
ALKBH4/Fe(II)/NOa 4.08, 3.97, 2.00 0.010 3/2 [Fe(II)–NO complex] Recorded under reducing conditions (Na2S2O4)
ALKBH4/Fe(II)/2OG/NOa 4.08, 3.97, 2.00 0.010 3/2 [Fe(II)–NO complex] Recorded under reducing conditions (Na2S2O4)
ALKBH4/Fe(II)/succinate/NOa 4.10, 3.93, 2.00 0.015 3/2 [Fe(II)–NO complex] Recorded under reducing conditions (Na2S2O4)
H169A/D171A/Fe(II)/NO ∼4.00, 2.02 n.d. 3/2 [Fe(II)–NO complex], 1/2 (NO• radical) Recorded under reducing conditions (Na2S2O4); NO• radical was
the major species, Fe(II)–NO complex was a minor species
ALKBH4/Fe(III)/2OG/Na2Sa 8.24, 5.56, 4.26, 2.10 0.120 5/2 [Fe(III)], 1/2 [Cu(II)] Transient species within the Fe(II)→Fe(III) oxidation process.
Cu(II) was a minor species
ALKBH4/Fe(III)a 9.40, 4.26, 2.10 0.250 5/2 [Fe(III)], 1/2 [Cu(II)] Cu(II) was a minor species
H169A/D171A/Fe(III) 4.28, 2.10 1/3 5/2 [Fe(III)], 1/2 [Cu(II)] Non-speciﬁcally bound Fe(III). Cu(II) was a minor species
ALKBH4/Fe(III)/2OGa 9.40, 4.26, 2.10 0.250 5/2 [Fe(III)], 1/2 [Cu(II)] Cu(II) was a minor species
ALKBH4/Fe(III)/succinatea n.d. n.d. n.d. Protein precipitation
aThe same features were observed for the C15A/C17A mutant protein.
bThe same features were observed for the H169A/D171A mutant protein.
Anaerobic incubation of ALKBH4 with 2OG and Fe(II) in the
presence of Na2S (10-fold excess), followed by addition of O2 and
fast quenching at liquid-N2 temperature (77 K, –196 ◦C), resulted
in a transient EPR-active species that exhibited resonances at
geff = 8.24, 5.56 and 4.26 (Figure 5). Upon thawing, this new
species relaxed fast (∼20 s) to the high-spin rhombic Fe(III)
ion with |E/D|;≈0.25, showing resonances similar to those
described in Figure 4(H). Identical behaviour was observed for
the C15A/C17A mutant, but not for the mutant H169A/D171A.
These effects suggest that the structural changes occuring in
the active site within the Fe(II)→Fe(III) oxidation process are
modulated further by the presence of Na2S. It is important to
note that similar signals and a similar decay process have been
reported in the non-haem Fe(III) centre present in photosystem
II, for example, decrease of the geff = 8.07 and geff = 5.58 signals
being accompanied by induction (increase) of the signal at the
geff = 4.26 signal, as a result of UV-B irradiation (280–320 nm)
[37,38]. These types of resonances have previously been analysed
by Weisser et al. [39] in terms of ZFS-distributed S = 5/2 systems
in Fe–catecholato complexes containing moderate rhombic
distortion (|E/D|≈0.12). Furthermore, EPR spectra similar to
those reported in Figure 5, although not transient, are observed
in Fe(III)–catecholato complexes as model systems of intradiol-
cleaving catechol dioxygenases [40], in PAH (phenylalanine
hydroxylase) in the presence of catecholamine feedback inhibitors
or even when recording PAH in Tris buffer [41,42].
The optical signatures of ALKBH4 and mutant proteins probed
by UV–Vis absorption spectroscopy
In parallel with the low-temperature EPR experiments, the
optical ﬁngerprints of the various forms of ALKBH4 and mutants
[Fe(II)/Fe(III) in the presence of, and without, 2OG] were probed
by UV–Vis absorption spectroscopy. The electronic spectrum
of the puriﬁed ALKBH4 protein did not show absorption
features in the visible region (Figure 6A, dashed line). Similarly,
the C15A/C17A and H169A/D171A proteins gave featureless
spectra. Upon reconstitution with Fe(II), but in the absence of
2OG, both ALKBH4 and the C15A/C17A mutant developed a
broad and composite absorption band, extending from 400 nm
Figure 5 Transient EPR spectra of ALKBH4 recorded within the
Fe(II)→Fe(III) oxidation process
X-band EPR spectra of ALKBH4 (120 μM in 50 mM Hepes, pH 7.0) reconstituted with
stoichiometric amounts of Fe(II), 2OG (10-fold excess) and Na2S (10-fold excess), recorded
after addition of O2 followed by quenching after t = 5 s (upper trace) or t = 10 s (lower trace)
of the ice-cooled solutions down to liquid-N2 temperature (T = 77 K). The measurements were
performed at T = 8.0 +− 0.5 K; frequency, 9.67 GHz; modulation frequency, 100 KHz; modulation
amplitude, 0.7 mT; gain, 55 dB; time constant, 81.92 ms; sweep time, 323 s; microwave power,
0.8 mW; cavity quality factor Q = 4200–4400; two scans were accumulated and averaged.
(λ= 404 nm, ε≈570 M− 1 · cm− 1) to 600 nm (λ= 490 nm,
ε≈260 M− 1 · cm− 1) (Figure 6A, dashed and dotted line).
However, the strong absorption band around 320 nm, due to
the presence of Na2S2O4 (reducing equivalents) in the medium,
masked an additional high-energy absorption signature, around
350 nm (ε≈920 M− 1 · cm− 1), as substantiated in those samples
reconstituted with Fe(II) without the supply of reducing agents
(Figure 6A, continuous line). When a 10-fold excess of 2OG was
added under reducing conditions, a slightly different chromophore
(λ= 430 nm, ε≈440 M− 1 · cm− 1) developed quickly in both
ALKBH4/Fe(II) and the C15A/C17A/Fe(II) protein (Figure 6B,
dotted line), with an absorption envelope similar to that
observed by Henshaw et al. [43] in E. coli AlkB in the
presence of Fe(II)/2OG. Upon oxidation, both ALKBH4/Fe(II)
and the C15A/C17A/Fe(II) mutant showed the formation of an
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Figure 6 UV–Vis absorption spectroscopy of Fe-reconstituted ALKBH4
(A) Puriﬁed ALKBH4 (dashed line), ALKBH4/Fe(II) recorded under anaerobic conditions in the
absence of Na2S2O4 (dotted line), and ALKBH4/Fe(II) recorded under anaerobic conditions
in the presence of Na2S2O4 (dashed and dotted line) and after oxidation (continuous line).
(B) ALKBH4/Fe(II)/2OG recorded under anaerobic conditions in the presence of Na2S2O4
(dotted line) and after oxidation (continuous line). Note that the spectrum showing the optical
feature of puriﬁed ALKBH4 (dashed line) from (A) is also included here for easier comparison.
(C) ALKBH4/Fe(II)/2OG recorded in the presence of Na2S2O4 after addition of NO gas under
anaerobic conditions (continuous line) and after oxidation (dotted line). The corresponding
spectrum of the H169A/D171A mutant [incubated with Fe(II) and 2OG] after NO exposure under
anaerobic conditions is shown as a dashed line. Protein concentrations were 0.22 mM in 50 mM
Hepes, pH 7.0, cooled solutions (T10◦C). Abs, absorbance.
absorption band centred at 530 nm (ε≈920 M− 1 · cm− 1),
being accompanied by the appearance of a shoulder at higher
energy (λmax = 370 nm, ε≈2000 M− 1 · cm− 1) (Figure 6A,
continuous line). Similarly, upon oxidation of Fe(II)- and
2OG-reconstituted ALKBH4 and C15A/C17A protein, an
absorption band that was slightly blue-shifted (λmax = 520 nm,
ε≈860 M− 1 · cm− 1) was detected together with a shoulder at
λmax = 404 nm (ε≈1580 M− 1 · cm− 1) (Figure 6B, continuous
line). None of the above-reported absorptions were observed
in the H169A/D171A mutant, neither in the Fe-reduced nor
-oxidized state. Reconstitution of ALKBH4 and the C15A/C17A
protein with a 5-fold excess of Fe(II) metal ions prior to
oxidation did not result in any further increase of the absorption
features in the visible regions. These ﬁndings reinforce the
hypothesis that (i) ALKBH4 is mononuclear in Fe content,
(ii) the cysteine-rich N-terminal site does not provide an
additional binding centre for the Fe(II)/Fe(III) metal ion, and
furthermore (iii) an intact histidine-carboxylate site is necessary
for productive Fe binding, in agreement with the results obtained
in the 2OG-decarboxylation-activity assay. Since the optical
features of both ALKBH4 and the C15A/C17A protein are
clearly modulated by the presence of 2OG, these differences may
indeed mirror modiﬁcations in the Fe co-ordination environment
upon interaction with the substrate, such as the displacement of
previously co-ordinated water molecules to the metal Fe. In the
present study, the development of rather strong chromophores
around 520–530 nm in the Fe(III) ALKBH4 and C15A/C17A
protein forms closely resemble the optical spectra observed in
synthetic models of non-haem Fe(III)–catecholato/phenolato
complexes [40]. Therefore the spectroscopic behaviour displayed
especially for the Fe(III) forms of ALKBH4 and the C15A/C17A
mutant is different from that previously observed for analogous
non-haem Fe proteins, such as AlkB and the Fe(II)/2OG-
dependent TauD (taurine dioxygenase). AlkB exhibits an
absorption band at λmax = 560 nm (ε = 1258 M− 1 · cm− 1) [44]
or, as found in other reports [12,43], a much weaker broad band
at 450–500 nm, whereas TauD shows an absorption band at
λmax = 530 nm (ε = 140 M− 1 · cm− 1) [45], when both 2OG and
Fe(II) are present under strict anaerobic conditions. In these
proteins, exposure to oxygen in the absence of primary substrate
causes the development of greenish-brown chromophores. In
TauD (λmax = 550 nm, ε = 700 M− 1 · cm− 1), the absorption
envelope in the oxidized protein arises from a self-hydroxylation
reaction of a tyrosine residue (Tyr73) near the non-haemmetal site
[45]. In AlkB, the formation of a greenish-brown chromophore
upon oxidation (λmax = 595 nm, ε = 960 M− 1 · cm− 1) indicates
a similar self-hydroxylation process that involves Trp178 [43]. In
order to further study the O2-binding properties of ALKBH4,
we followed the optical changes of the Fe(II) metal core upon
interaction with the dioxygen analogue NO, as performed in
the EPR experiments reported earlier. Addition of NO to an
anaerobic solution of ALKBH4 containing Fe(II), 2OG and
Na2S2O4 produced a strong yellowish-green chromophore, with
a broad absorption band around 580 nm (ε≈620 M− 1 · cm− 1)
being accompanied by a more intense peak at 436 nm (ε≈2430
M− 1 · cm− 1) (Figure 6C, continuous line). A similar spectrum
was obtained for the C15A/C17A mutant (results not shown).
These optical features closely resemble those reported for other
non-haem Fe proteins [46] anaerobically treated with NO, such
as PAH (λmax = 440 nm, ε≈2300 M− 1 · cm− 1) in the presence
of its co-substrate tetrahydropterin [47], which exhibits, in
addition, similar EPR resonance to our NO complex. However,
after injection of oxygen, the Fe(II)–NO adduct decayed into a
greenish-brown chromophore (λ= 580 nm, ε≈620 M− 1 · cm− 1,
and λ= 770 nm, ε≈270 M− 1 · cm− 1) (Figure 6C, dotted line),
without recovery of the optical features for the Fe(III) form
shown previously (Figure 6B, continuous line). This might
indicate that the protein becomes more sensitive towards side
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reactions upon NO binding and subsequent oxidation, since the
recorded envelope in this case is very similar to the one observed
in AlkB upon Trp178 hydroxylation [43]. Large differences
can also be seen between ALKBH4 (and the C15A/C17A
mutant) and the H169A/D171A mutant with respect to NO
reactivity. After addition of NO to the colourless solution of the
H169A/D171A/Fe(II)/2OG protein under anaerobic conditions,
a yellowish solution formed without the emergence of any of
the Fe–NO characteristic absorption bands, apart from a very
broad absorption envelope, extending from 350 nm to 700 nm
(Figure 6C, dashed and dotted line). This result supports the
previous observation from the low-temperature EPR spectra
(Figure 4D) that only a minor amount of Fe–NO adduct can
be formed in the case of the H169A/D171A mutant, with the
majority of the supplied Fe metal ions non-speciﬁcally bound to
the protein.
Conclusions
In the present work, we have addressed the characteristics
(electronic and magnetic) of the Fe metal core in the human
AlkB homologue ALKBH4, and we have shown that an intact
His169-Asp171-His254 motif is necessary for productive Fe binding
and for decarboxylation activity towards 2OG. Furthermore,
we have shown that the N-proximal cysteine-rich motif of
ALKBH4 is not involved in Fe binding. Although the biological
function of ALKBH4 remains elusive, its ability to bind and
decarboxylate 2OG after metal reconstitution, together with the
optical and spectroscopic ﬁngerprints of its suggested catalytic
centre, conﬁrm for the ﬁrst time that ALKBH4 truly belongs to
the class of 2OG-dependent mononuclear non-haem Fe proteins.
Additional work is needed to determine the nature of the transient
species detected within the reoxidation process in the presence of
Na2S.
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Abstract
The Fe(II)- and 2-oxoglutarate (2OG)-dependent dioxygenase AlkB from E. coli is a demethylase which repairs alkyl lesions in
DNA, as well as RNA, through a direct reversal mechanism. Humans possess nine AlkB homologs (ALKBH1-8 and FTO).
ALKBH2 and ALKBH3 display demethylase activities corresponding to that of AlkB, and both ALKBH8 and FTO are RNA
modification enzymes. The biochemical functions of the rest of the homologs are still unknown. To increase our knowledge
on the functions of ALKBH4 and ALKBH7 we have here performed yeast two-hybrid screens to identify interaction partners
of the two proteins. While no high-confidence hits were detected in the case of ALKBH7, several proteins associated with
chromatin and/or involved in transcription were found to interact with ALKBH4. For all interaction partners, the regions
mediating binding to ALKBH4 comprised domains previously reported to be involved in interaction with DNA or chromatin.
Furthermore, some of these partners showed nuclear co-localization with ALKBH4. However, the global gene expression
pattern was only marginally altered upon ALKBH4 over-expression, and larger effects were observed in the case of ALKBH7.
Although the molecular function of both proteins remains to be revealed, our findings suggest a role for ALKBH4 in
regulation of gene expression or chromatin state.
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Introduction
The superfamily of Fe(II)- and 2-oxoglutarate (2OG)-dependent
dioxygenases comprise enzymes which catalyze oxidation reac-
tions in a diverse set of biological processes such as post-
translational modification of collagen, the hypoxic response
pathway and epigenetic regulation [1–6]. These proteins are
characterized by their catalytic requirement for ferrous iron as well
as the co-substrate 2OG. The primary oxidation reactions they
catalyze are coupled to decarboxylation of 2OG, yielding
succinate and CO2. The E. coli AlkB protein [7] is an Fe(II)/
2OG dioxygenase involved in DNA and RNA repair, and is
induced as part of the adaptive response to alkylation damage.
Targeting alkyl lesions at N1-position in purines and N3-position
in pyrimidines, AlkB directly reverses the base damage by an
oxidative mechanism that involves hydroxylation of the alkyl
group, which is consequently destabilized and spontaneously
released [8,9]. The repertoire of AlkB substrates has extended
from the originally identified simple methyl lesions 1-methylade-
nine (1-meA) and 3-methylcytosine (1-meC), to also comprise
larger adducts, such as ethyl, propyl and etheno groups [10–13], as
well as methylated RNA [14].
In mammals, nine AlkB homologs have been reported;
ALKBH1-8, as well as the fat mass and obesity protein (FTO)
[15,16]. ALKBH2 and ALKBH3 have similar activities as AlkB,
ALKBH2 being most active on dsDNA, while ALKBH3
preferentially demethylates ssDNA and ssRNA [14]. FTO has
also, with its weak activity towards 3-methylthymine (3-meT) in
ssDNA and 3-methyluracil (3-meU) in ssRNA, been implicated in
nucleic acid repair [16,17], but the recent identification of N6-
methyladenosine (6-meA) in ssRNA as a preferred substrate
indicates a role for FTO in regulating mRNA modification [18].
With the recent demonstration of ALKBH8 being involved in
hypermodification of tRNA wobble uridines [19–22], the function
of the mammalian ALKBH proteins was definitely shown to
extend beyond nucleic acid repair. ALKBH1, the mammalian
homolog with highest similarity to AlkB, has also been reported to
display DNA repair activity [23]. However, the significance of this
activity, which has not been confirmed by others, is unclear, and
there are indications rather pointing towards a function for
ALKBH1 in epigenetic gene regulation, potentially through
histone demethylation [24,25], thereby supporting the suggestion
that some of the human ALKBHs are involved in protein
demethylation [26,27]. In line with this, the S. pombe AlkB homolog
Ofd2 was recently reported to interact with histones [28]. While 2-
oxoglutarate decarboxylase activity has been demonstrated for
ALKBH4 and ALKBH5 [29,30], their primary substrates and
biological functions still remain, together with those of ALKBH1,
ALKBH6 and ALKBH7, to be revealed.
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The present study focuses on the human ALKBH4 and
ALKBH7 proteins. Through yeast two-hybrid screening, we show
binding of ALKBH4 to several proteins with associations to
chromatin regulation and transcription. Furthermore, for a selec-
tion of these, we demonstrate nuclear co-localization with
ALKBH4. However, as revealed through gene expression pro-
filing, ALKBH4 over-expression marginally affects the expression
pattern in HEK293 cells, while over-expression of ALKBH7
influences biological pathways such as cell cycle, DNA repair and
spermatogenesis, and positively regulates a number of genes
involved in meiotic recombination. Thus, this work provides novel
insight into the biological function of mammalian AlkB homologs
for which no biochemical activity has yet been reported.
Results
Yeast Two-hybrid Screens Identified ALKBH4 Binding
Partners Involved in Transcription
To improve our knowledge on ALKBH4 and ALKBH7
function, we searched to identify interaction partners of these
proteins through yeast two-hybrid (Y2H) screens. Screens were
performed using ALKBH4 as bait against two different human
libraries, one from placenta and another from fetal brain
(Hybrigenics, France). ALKBH7 was used as bait to screen the
fetal brain library. While we did not obtain any hits considered
highly confident in the ALKBH7 screen, a total of ten such hits
were detected in the two screens concerning ALKBH4 (Table 1).
Notably, five of these proteins have been associated with
transcription and chromatin modification, suggesting a function
of ALKBH4 in gene regulation. Of these, the transcriptional co-
activator and histone acetyltransferase (HAT) p300 [31] was the
only protein identified in both screens and, of note, the highly
similar p300 paralog CBP was not detected in any of them. The
homeotic transcription factor ATBF1 [32,33] and the tissue
specific heat-shock transcription factor HSF4 [34,35] were
identified as ALKBH4 partners exclusively in the placenta screen.
The proteins AF9 and ENL, which have similar biological
functions and display very high sequence homology (56% identity
throughout the entire sequence) [36] were identified in the
placenta and brain screens, respectively. The specific functions of
AF9 and ENL are currently unknown, but they have both been
associated with histone modification and transcriptional elonga-
tion [37–39].
To further investigate whether the observed interactions are
dependent on the enzymatic activity of ALKBH4, an enzymat-
ically inactive mutant (ALKBH4H169A/D171A) was used as bait in
a Y2H screen against the placenta library. Notably, this screen
retrieved a very similar set of proteins as the screen performed with
wild-type ALKBH4 (Table 1), indicating that the observed
interactions can occur independently of the oxygenase activity of
ALKBH4.
ALKBH4 Binding is Mediated by Chromatin-associated
Domains
The clones identified in the Y2H screens usually represented
non-full-length fragments of the interactants. The overlapping
sequences present in all clones representing the same partner
protein define the part of the protein that is responsible for the
interaction, the so-called selected interaction domain (SID). A
schematic representation of the transcription/chromatin-related
high confidence hits, depicting the SID involved in the interaction
with ALKBH4, is shown in Figure 1. Interestingly, for all five
proteins the SID encompassed only a limited region, and in all
cases this region included annotated domains reported to interact
with DNA and/or chromatin. For both AF9 and ENL, the
ALKBH4-interacting part mapped to the chromatin-associated
YEATS domain, while the portion of ATBF1 that binds ALKBH4
was shown to encompass two of the numerous C2H2-type zinc
fingers found in this protein. Moreover, we found the interaction
between ALKBH4 and HSF4 to be mediated through the amino-
terminal DNA binding domain (DBD) of the latter. Finally, the
region of p300 mediating the ALKBH4-interaction covered both
the bromodomain and plant homeodomain (PHD).
Since this region is adjacent to the HAT domain and since
bromo domain are known to bind to acetylated proteins, we
considered the possibility that ALKBH4 is acetylated by p300. To
address this issue, we used an anti-FLAG antibody to immuno-
precipitate FLAG-ALKBH4 from cell extracts containing over-
expressed p300 as well as FLAG-ALKBH4. However, no in vivo
ALKBH4 acetylation was detected (data not shown).
ALKBH4 Co-localizes with the Transcriptional Proteins
AF9, ENL and p300 in the Nucleoplasm and Nucleoli
We have made extensive efforts to verify the interactions that
were observed in the Y2H screen by independent methods, such as
pull-down experiments with recombinant GST-tagged proteins
and co-immunoprecipitation of tagged, co-expressed proteins from
cell lysates (experimental outlines can be found in the Materials
and Methods section). However, none of these efforts were
successful with respect to robust verification, possibly because the
interactions are transient and of low affinity. Nonetheless, given
the striking overrepresentation of DNA/chromatin binding
moieties of transcription-associated proteins among the interac-
tions, we still considered it likely that the corresponding
interactions are biologically relevant and occurring in mammalian
cells in vivo. To investigate this, the chromatin-related proteins that
were detected in both screens, AF9, ENL and p300, were selected
for co-localization studies with ALKBH4. HeLa cells were
transiently co-transfected with a plasmid encoding ALKBH4
fused to either Enhanced Cyan Fluorescent Protein (ALKBH4-
ECFP) or Enhanced Yellow Fluorescent Protein (ALKBH4-EYFP)
in combination with plasmids encoding EYFP/ECFP-fusions of
the selected partner proteins or truncations of these, and
localization patterns were analyzed by confocal microscopy. First,
we determined the subcellular localization of ALKBH4
(ALKBH4-EYFP) alone, which, consistent with a previous report
[40], was found to be localized both in the nucleus and the
cytoplasm, with similarly strong signals detected in the two
compartments (Figure 2A).
Co-localization with the AF9/ENL YEATS
domain. ALKBH4 showed nuclear co-localization with both
AF9 and ENL in which partial overlap in distinct spots in
nucleoplasm and nucleoli was observed for both proteins
(Figure 2B and 2C and data not shown). In order to address the
significance of the YEATS domain for these presumable
interactions, we examined the co-localization patterns of
ALKBH4 with two truncated ENL versions, which expressed
either the YEATS domain (EYFP-ENLYEATS) or the C-terminal
part (ENLC-EYFP). A co-localization pattern similar to that of full-
length ENL was obtained for the YEATS only version (Figure 2D).
However, deletion of the YEATS domain strongly reduced the co-
localization of ENL with ALKBH4 in nucleoli (Figure 2E). This
supports the results from the Y2H screens, strengthening the
indication of an interaction between ALKBH4 and AF9/ENL,
with the YEATS domain of latter being important for mediating
the interaction.
Co-localization with the bromodomain and PHD finger of
p300. In our Y2H screens, the p300 clones identified to bind
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PLOS ONE | www.plosone.org 2 November 2012 | Volume 7 | Issue 11 | e49045
ALKBH4 all encompassed both the bromodomain and PHD
finger, a protein domain combination that has been shown to
compose a functional protein moiety [41]. Thus, in order to
determine if p300 co-localizes with ALKBH4, we decided to use
an EYFP-tagged fragment of p300 covering the region of the
bromodomain and PHD only (aa 1039–1285, EYFP-p300BP),
instead of the full-length protein. Indeed, similar to what was
observed for AF9 and ENL, p300BP co-localized with ALKBH4 in
spots in nucleoli (Figure 2F). A similar nuclear localization pattern
and nucleolar presence has been previously reported for over-
expressed, full-length p300 [42]. Our results thus indicate an
interaction between ALKBH4 and p300BP. However, the in-
Table 1. High confidencea ALKBH4 interacting proteins identified by the yeast two-hybrid system.
Cellular process Gene Length (aa) SIDb
Domain(s)
encompassed by SID Screen
Fetal brain Placenta Placenta (ALKBH4H169A/D171A)
Transcription ATBF1 3703 1545–1626 C2H2 zinc fingers 2 + +
AF9 568 10–151 YEATS + 2 2
ENL 559 4–151 YEATS 2 + (+)c
HSF4 462 1–93 DBD 2 + +
p300 2414 1054–1352 Bromodomain, PHD + + +
Other TES 421 1–375 PET, LIM1–2 2 + +
EIF3C 914 749–882 PCI +d + 2
MTMR6 621 251–539 PTP + (+)c 2
PSMA6 246 11–232 Proteasome + 2 2
GID: 13396337 242 13–66 Transmembrane domain + 2 2
aPBS (predicted biological score) of A or B. PBS (calculated according to [75]) represents the probability of an interaction to be non-specific, and refers to an e-value with
defined thresholds to rank the results in the high-to-low confidence categories A–D.
bSID (selected interaction domain) refers to the amino acid region shared by all prey fragments matching the same reference protein,
c(+) Low confidence hit (PBS D),
dEIF3CL. Grey shade, transcription related interactants. YEATS, Yaf9 ENL AF9 TAF14 Sas5; DBD, DNA binding domain; PHD, plant homeodomain; PET, Prickle Espinas
Testin; LIM, Lin-11 Isl-1 Mec-3; PCI, Proteasome, COP9, Initiation factor-3; PTP, protein tyrosine phosphatase.
doi:10.1371/journal.pone.0049045.t001
Figure 1. Schematic representation of yeast two-hybrid high confidence hits involved in transcription. Individual prey fragment clones
and the resulting selected interaction domains (SIDs) reported to bind ALKBH4 are indicated above each protein; black lines, placenta library; orange
lines, fetal brain library; green lines, placenta library screened with ALKBH4H169A/D171A; red dashed lines, SIDs. Grey boxes indicate protein domains.
Proteins and domains are drawn to scale according to the InterPro (version 4.8) and PROSITE (release 20.68) databases [73,74].//indicates regions
omitted for simplicity. ZnF, C2H2 zinc finger; HD, homeodomain; YEATS, Yaf9 ENL AF9 Taf14 Sas5; TAZ, transcription adaptor putative zinc finger; BRD,
bromodomain; PHD plant homeodomain; HAT histone acetyl transferase; DBD, DNA binding domain. Bar, 100 aa.
doi:10.1371/journal.pone.0049045.g001
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dividual contribution of the two domains considered here can not
be determined from this experiment.
ALKBH4 Partly Co-localizes with the RNA Polymerase I
Complex
Being the site of ribosome biogenesis, the nucleolus also
comprises the process of ribosomal RNA (rRNA) synthesis. Our
observations of ALKBH4 co-localizing in nucleolar foci with all
three transcription-associated proteins examined made us specu-
late if ALKBH4 could potentially have a function in transcription
of ribosomal DNA (rDNA) genes. We therefore examined whether
ALKBH4 and ENL co-localize with the RNA polymerase I
subunit RPA43. Thus, HeLa cells were transiently co-transfected
with plasmids encoding ALKBH4-EYFP, ECFP-ENL and a Red
Fluorescent Protein (RFP)-fusion of RPA43 (RPA43-RFP). RPA43
was observed at the surroundings of the distinct nucleolar
ALKBH4/ENL foci with partially overlapping staining observed
(Figure S1, insert and nucleolus at the lower right). Partial co-
localization of ALKBH4 with ENL in nucleoplasmic and nucleolar
spots was detected, as mentioned above. Notably, we observed
a larger amount of ENL foci overlapping with RPA43 foci
compared to the overlap between ALKBH4 and RPA43. Hence,
these results suggest that ALKBH4 is not primarily involved in
nucleolar RNA polymerase I-dependent rDNA transcription.
Effects of ALKBH4 and ALKBH7 on Global Gene
Expression and DNA Methylation Patterns
We further considered the possibility that ALKBH4 may itself
be capable of modulating transcription. To investigate this, we
generated a stable HEK293 cell line in which the ALKBH4
encoding gene was introduced at a specific, transcriptionally
active, genomic locus, behind a tetracycline-inducible promoter,
thereby enabling controlled over-expression of ALKBH4. Ectopic
ALKBH4 expression was induced upon treatment with the
tetracycline analog doxycycline (DOX), and the resulting
ALKBH4 increase was verified on the mRNA and protein levels,
by qPCR and Western blotting, respectively (Figures 3A and B).
The global gene expression profiles of the ALKBH4 over-
expressing cell line and the non-induced, parental cell line were
subsequently compared in a microarray-based genome-wide
expression analysis. Surprisingly, very small effects on gene
expression were observed upon over-expression of ALKBH4.
Actually, none of the genes were up- or down-regulated above 2-
fold, and only 22 genes showed differential expression when the
fold change stringency was reduced to 1.35 (Figure 3C). A list of
differentially expressed genes (q-value ,5, fold change (FC)
.1.35) upon ALKBH4 over-expression is shown in Table 2.
Noteworthy, the absence of ALKBH4 itself among the up-regulated
genes in the over-expressing cell line is explained by annealing of
the probe to the untranslated region (UTR) of the gene (data not
shown). The low number of genes affected by ALKBH4 over-
expression indicates that ALKBH4 does not affect transcription at
the global level in the HEK293 cells.
Furthermore, to characterize the biological functions of the
genes affected by ectopic ALKBH4 expression, a gene ontology
(GO) analysis was performed using MetaCore GeneGo Pathways
Analysis software (GeneGo Inc.). However, the differentially
expressed genes were not enriched in any molecular pathway.
Several mammalian AlkB homologs have been shown to be
involved in DNA/RNA transactions, and these are basic proteins
with a high pI value, thus allowing binding to the negatively
charged nucleic acid backbone. In contrast, ALKBH1, ALKBH4
and ALKBH7 are acidic proteins, and it has been proposed that
they may be involved in demethylating histones or other proteins
(Sedgwick et al. 2007). Indeed, genetic ablation of ALKBH1 has
been shown to dysregulate a number of genes in the mouse
placenta [24], and we were therefore also interested in in-
vestigating the effects of ALKBH7 on gene regulation. Using the
same approach as for ALKBH4, we generated a stable HEK293
cell line with tetracycline-inducible over-expression of ALKBH7,
which was used to determine the effects of ectopic ALKBH7 levels
on gene expression. Considerably stronger effects were detected in
the case of ALKBH7, compared to ALKBH4. A total of 532
genes, excluding ALKBH7, were differentially expressed (q-value
,5, FC .2) between the parental and ALKBH7 over-expressing
cell lines. Of these, 197 genes were up-regulated and 335 genes
were down-regulated (Figure 3C). Notably, ALKBH7 over-
expression resulted in a higher number of down-regulated
compared to up-regulated genes and, moreover, the most down-
regulated genes were more strongly affected (3.8, FC ,5.4) than
the most up-regulated ones (2.9, FC ,3.4). The most up- or
down-regulated genes are listed in Table 3.
In order to determine possible enrichment of ALKBH7 affected
genes in certain biological pathways, we further performed a GO
analysis similar to that of ALKBH4. Twelve GO categories were
determined to be significantly overrepresented (false discovery rate
(FDR) ,0.05) among the differentially expressed genes
(Figure 3D). The pathway mostly enriched with ALKBH7 affected
genes was ‘‘cell cycle and its regulation’’, in which 33 of 444 genes
displayed expression level alterations upon ectopic ALKBH7
expression. While the great majority of these (31 genes) showed
decreased expression, only two genes, RBX1 (RING-box protein 1)
and PRKAR1A (PKA-regulatory subunit 1A), were up-regulated.
ALKBH7 is annotated in the NCBI database as spermatogen-
esis-associated protein 11 (SPATA11) or spermatogenesis cell
proliferation-related protein. Interestingly, the results of our
GeneGo pathway analysis included ‘‘spermatogenesis’’ as a cate-
gory of enriched genes (Figure 3D). Herein, three genes (CREB1,
PRKAR1A and GNAS1) of a total of 22, belonging to the sub-
category ‘‘transcription – CREM signaling in testis’’, were
differentially expressed after ALKBH7 over-expression. Moreover,
among the top twenty up-regulated genes, three genes involved in
the process of meiotic recombination during gametogenesis were
identified: disrupted meiotic cDNA 1 (DMC1) [43], decreased sperm
survival 1 (DSS1) [44] and male-specific lethal 3-like 1 (MSL3L1) [45].
Thus, our results are consistent with an association of the ALKBH7
gene with spermatogenesis.
To complement the gene expression data, we also performed
microarray-based CpG methylation profiling in cells over-expres-
sing either ALKBH4 or ALKBH7, as well as in the respective non
over-expressing cells. In case of both proteins, the methylation
pattern remained strikingly constant upon over-expression
(r2 = 0.9975 and 0.9916 for ALKBH4 and ALKBH7, respectively.
Figure S2), thus excluding a role for ALKBH4 and ALKBH7 in
regulation of global CpG methylation.
Figure 2. Subcellular localization of ALKBH4 and its co-localization with transcription-associated proteins. (A) Subcellular localization
of ALKBH4-EYFP in HeLa cells. Co-expression of (B) ALKBH4-ECFP and AF9-EYFP, (C) ALKBH4-EYFP and ECFP-ENL, (D) ALKBH4-ECFP and EYFP-
ENLYEATS, (E) ALKBH4-ECFP and ENLC-EYFP and (F) ALKBH4-ECFP and EYFP-p300BP, as analyzed by confocal fluorescence microscopy. Insets are
enlargements of boxed areas.
doi:10.1371/journal.pone.0049045.g002
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In vivo H3K79 Methylation Levels are not Affected by
Ectopic ALKBH4 Expression
Regulation of transcription depends on dynamic chromatin
modifications, such as histone methylation, involving proteins with
either methyltransferase or demethylase activity. In contrast to the
situation for methylated lysine residues found at the flexible
histone tails, no demethylase has been found to reverse the
activating methyl mark at the lysine 79 (K79) residue in the
globular domain of H3, which in mammals is introduced by the
enzyme DOT1L. However, there are indications of the existence
of such enzyme activity [46,47], and a study in which treatment of
cells with 2-hydroxyglutarate (2HG), an inhibitor of Fe(II)/2OG-
dependent oxygenases, resulted in increased H3K79 dimethyl
levels has further suggested a member of this protein family to be
the enzyme responsible for H3K79 demethylation [48]. Moreover,
ALKBH4 has previously been suggested to possess protein
demethylase activity [26], and our results imply a role for
ALKBH4 in chromatin regulation. Since we found ALKBH4 to
interact with the DOT1L-associated proteins AF9 and ENL, we
speculated that ALKBH4 could potentially function as a demethy-
lase with specificity for methylated H3K79. In order to address
this issue, we isolated histones from the DOX-inducible ALKBH4
over-expressing HEK293 cell line before and after DOX
induction, as well as from a similarly generated cell line possessing
the ability of stable, inducible over-expression of an enzymatically
inactive ALKBH4 mutant (ALKBH4H169A/D171A). Subsequently,
the methylation status at the H3K79 position in the histones was
determined by Western blotting. However, we did not observe any
effect of ectopic ALKBH4 expression on the methylation status of
histone H3K79, as similar levels of mono-, di- and trimethylated
H3K79 were detected in the non-overexpressing cells as well as in
those over-expressing ALKBH4H169A/D171A (Figure 4). This
suggests that ALKBH4, if involved in demethylation of this
histone residue, might be restricted to certain, presently unknown,
conditions to be functional.
Discussion
In the present work, we report that proteins involved in
transcription were strongly over-represented among interactants of
the human oxygenase ALKBH4 identified by Y2H screens, while
no convincing partners were detected for the related ALKBH7
protein. Interestingly, the regions of these transcription-associated
interactants that was responsible for interaction with ALKBH4, in
Figure 3. Effects of ectopic expression of ALKBH4 or ALKBH7 on global gene expression. (A) Quantitative RT-PCR analysis of relative
ALKBH4 levels in HEK293 cells stably transfected with a construct for DOX-inducible over-expression of ALKBH4-FLAG, either treated with DOX (2 mg/
ml) or untreated. Results are presented as mean fold change of three independent replicates normalized to b-actin6 S.D. (B) Ectopic ALKBH4 protein
levels in DOX-induced and non-induced cells, as determined by Western blot analysis. Ectopic ALKBH4 was detected using an antibody against the
FLAG-tag introduced at the C-terminus of ALKBH4. GAPDH expression levels are included as loading control. (C) Microarray analysis of gene
expression in cells over-expressing either ALKBH4 or ALKBH7 vs. non-overexpressing cells. The number of genes whose expression is altered at least
2.0-fold (ALKBH7) or 1.35-fold (ALKBH4) is indicated (D) MetaCore (GeneGo Inc.) analysis of molecular pathways significantly (False discovery rate
(FDR) ,0.05) enriched with genes affected by ectopic ALKBH7 expression. DOX, doxycycline.
doi:10.1371/journal.pone.0049045.g003
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all cases encompassed domains which are involved in interaction
with DNA and chromatin, and for some of these interactants we
observed a co-localization with ALKBH4 in distinct foci in the
nucleus. We also performed a global analysis of gene expression
and CpG methylation changes induced by ectopic over-expression
of ALKBH4 and ALKBH7. While we saw rather small effects of
ALKBH4 on both expression and methylation, larger effects on
gene expression were observed in the case of ALKBH7.
Protein Partners Suggest a Role for ALKBH4 in Gene
Regulation
Our identification of the transcriptional co-activator p300 as an
ALKBH4 partner is indicative of a gene regulatory role of
ALKBH4. The region of p300 mediating the ALKBH4-in-
teraction covered both the bromodomain and plant homeodomain
(PHD) of this protein. Both domains represent motifs found in
chromatin modification effector proteins, thus functioning in
recruitment of remodeling-complexes to chromatin. While bro-
modomains recognize acetylated histones [49], the zinc-coordi-
nating PHD finger is generally involved in binding methylated or
unmodified histone H3 [50]. However, PHD fingers are often
found close to bromo- or chromodomains [51], and several reports
have shown a combinatorial function of the two domains [52,53].
The function of the p300 PHD finger is still to be elucidated,
although it has been reported to be required, together with the
bromodomain, for in vitro recognition of acetylated nucleosomes
[41]. Notably, the histone acetyl transferase CBP, which is highly
similar to p300, was not identified as an ALKBH4 interaction
partner in the yeast two-hybrid screen. However, p300 HAT
activity does not, in contrast to that of CBP, depend on its PHD
finger, implying non-redundant functions for these co-activators
[54].
Further supporting an involvement of ALKBH4 in gene
regulation, we also detected the homologs AF9 and ENL as
interacting partners. In addition to a hydrophobic, transcription-
associated C-terminus both proteins contain an N-terminal
YEATS domain [37], which we here found to mediate the
ALKBH4 interaction. The YEATS domain has been named after
proteins that carry such a domain (Yaf9, ENL, AF9, Taf14 and
Sas5), and many of these proteins are components in transcrip-
tional or chromatin-modifying complexes. The specific function of
YEATS has not yet been determined, but several findings indicate
a role in chromatin binding. The interaction between ENL and
histones H1 and H3 has previously been demonstrated to be
mediated through YEATS [55], and recently, AF9/ENL YEATS
was found to be the module responsible for recruitment of the
super elongation complex (SEC) to chromatin and the elongating
Polymerase II [56]. Moreover, as a result of the first three-
dimensional YEATS structure, this domain was recently suggested
to provide an additional reader module of chromatin, analogous to
the bromodomain and PHD finger [57,58], with the Yaf9 YEATS
domain suggested to potentially bind acetylated lysine-residues in
histones [57].
The interactions of ALKBH4 with the transcription factors
HSF4 and ATBF1 were found to involve domains with the ability
of DNA binding, these being the DNA binding domain (DBD) of
Table 2. Differentially expressed genes (q-value ,5, fold change .1.35) identified in ALKBH4 over-expressing cells compared to
parental non over-expressing cells.
Gene Description Fold Change
Up-regulated1 HSPA1B Heat shock 70kDa protein 1B 1.63
INSIG1 Insulin induced gene 1, transcript variant 2 1.43
LAMA5 Laminin, alpha 5 1.43
FAM38A Family with sequence similarity 38, member A 1.39
HSPA8 Heat shock 70kDa protein 8, transcript variant 1 1.38
LOC642031 Hypothetical protein LOC642031 1.38
FASN Fatty acid synthase 1.36
LOC23117 KIAA0220-like protein, transcript variant 16 1.35
INTS1 Integrator complex subunit 1 1.35
SEC16A SEC16 homolog A 1.35
Down-regulated DDIT4 DNA-damage-inducible transcript 4 21.55
LGALS1 Lectin, galactoside-binding, soluble, 1 21.50
LETMD1 LETM1 domain containing 1, transcript variant 1 21.48
LOC653994 Similar to Eukaryotic translation initiation factor 4H, transcript variant 2 21.48
SLC3A2 Solute carrier family 3, member 2, transcript variant 6 21.45
CTH Cystathionase (cystathionine gamma-lyase), transcript variant 1 21.43
TSC22D3 TSC22 domain family, member 3, transcript variant 2 21.43
MCM7 Minichromosome maintenance complex component 7, transcript variant 1 21.38
DDIT3 DNA-damage-inducible transcript 3 21.37
STC2 Stanniocalcin 2 21.37
SNX5 Sorting nexin 5, transcript variant 1 21.37
RASSF1 Ras association (RalGDS/AF-6) domain family member 1, transcript
variant C
21.36
1The ALKBH4 probe was not detected due to annealing to the UTR of the gene. Sorted by fold change.
doi:10.1371/journal.pone.0049045.t002
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HSF4 and two of the multiple C2H2-type zinc fingers of ATBF1.
The versatile C2H2 motif, which is frequently found in gene
regulators, has been demonstrated to mediate interactions with
proteins as well as both DNA and RNA (reviewed in [59]).
Previously, two of the ATBF1 zinc fingers have been reported to
bind protein [60].
Interestingly, three of the transcription-associated ALKBH4
partners, AF9, ENL and p300, have all been reported to be fused
to the histone methyltransferase MLL in mixed-lineage leukemia
(MLL) [37,61,62], which is characterized by abberant H3K79
dimethylation profiles [63]. While the ALKBH4 interacting
YEATS domain of AF9/ENL is not present in the fusion proteins
MLL-AF9 and MLL-ENL [37], the less frequent MLL-p300
fusions, which are thought to promote leukemogenesis through
aberrant histone acetylation rather than methylation [61,64],
retain the ALKBH4 interacting p300 region.
Molecular Function of ALKBH4
Although the present work suggests that ALKBH4 may be
involved in processes such as chromatin regulation and transcrip-
tion, its molecular function remains an enigma. Interestingly, two
of the herein identified ALKBH4 interacting proteins with
associations to chromatin regulation and transcription, AF9 and
ENL, also interact with DOT1L, the enzyme responsible for
methylation of lysine 79 at histone H3 (H3K79). While no
demethylase with specificity for this residue has been reported so
far, there are indications of such activity [46,47]. The responsible
enzyme has been suggested to be an Fe(II)/2OG dioxygenase, as
elevated H3K79 dimethyl levels has been observed as a result of
Fe(II)/2OG dioxygenase inhibition [48]. Intriguingly, plants lack
both H3K79 methylation and DOT1L orthologs [65], as well as
ALKBH4. Thus, ALKBH4 could be imagined to function as an
H3K79 demethylase. Consequently, we investigated whether
ectopic ALKBH4 expression affected the cellular H3K79 meth-
ylation status in HEK293 cells. However, we did not detect
alterations in the levels of neither mono-, di- nor trimethylated
H3K79 after ALKBH4 over-expression. Related Fe(II)/2OG
dioxygenase activities include JumonjiC (JmjC) protein mediated
histone demethylation [2], structural and gene regulatory protein
hydroxylation by prolyl-4-hydroxylase (P4H) and prolyl hydrox-
ylase domain containing (PHD) 1–3, respectively [5,66], as well as
epigenetic DNA hydroxylation by the TET enzyme family, which
was recently reported to convert 5-methylcytosine (5-meC) to 5-
hydroxymethylcytosine (5-hmC) [1]. Previously, the low pI-value
of ALKBH4 has suggested this enzyme to possess a protein, rather
than a nucleic acid substrate [26], and, consistently, no activity
towards the classical AlkB substrates 1-meA and 3-meC has been
detected [67]. Furthermore, we previously showed uncoupled
decarboxylase activity for ALKBH4, indicating that this protein is
a bona fide Fe(II)/2OG dioxygenase [30].Thus, a demethylase or
hydroxylase activity targeting proteins or, less likely, nucleic acids,
could be envisioned for ALKBH4.
Association of Genes Affected by ALKBH7 Over-
expression with DNA Recombination
The previous annotation of ALKBH7 being associated with
spermatogenesis is consistent with the data presented here, as
functional annotation analysis revealed spermatogenesis as one of
the biological pathways enriched with genes differentially
expressed upon ectopic ALKBH7 expression. Meiotic recombi-
nation is one of the central events occurring during spermatogen-
esis, and, consistently, three genes with functions in meiotic
recombination were found among the twenty most up-regulated
ones. This, in combination with the over-representation of genes
related to cell cycle regulation and the DNA damage response
among the differentially expressed genes, may indicate a possible
role for ALKBH7 in the process of homologous recombination
repair (HRR) of double strand breaks (DSBs) introduced by DNA
Table 3. The genes most differentially expressed in either direction identified in ALKBH7 over-expressing cells compared to
parental non over-expressing cells.
Gene Description Fold Change
Up-regulated ALKBH7 AlkB, alkylation repair homolog 7 13.54
MSL3L1 Male-specific lethal 3-like 1, transcript variant 1 3.41
LOC643287 Similar to prothymosin alpha, transcript variant 1 (LOC643287) 2.97
RPL21 Ribosomal protein L21 2.96
NBPF20 Neuroblastoma breakpoint family, member 20 2.95
PEBP1 Phosphatidylethanolamine binding protein 1 2.90
GNL3L Guanine nucleotide binding protein-like 3 (nucleolar)-like 2.89
SHFM1 Split hand/foot malformation (ectrodactyly) type 1 2.85
Down-regulated LOC650215 Similar to Exportin-T (tRNA exportin) -5.42
PKMYT1 Protein kinase, membrane associated tyrosine/threonine 1, transcript variant 2 -4.53
GDF15 Growth differentiation factor 15 -4.43
LOC643031 Similar to NADH dehydrogenase subunit 5 -4.06
MAZ MYC-associated zinc finger protein, transcript variant 2 -3.93
CCT7 Chaperonin containing TCP1, subunit 7 (eta), transcript variant 1 -3.91
NGRN Neugrin, neurite outgrowth associated (NGRN), transcript variant 1 -3.87
LOC727761 Similar to Deoxythymidylate kinase, transcript variant 4 -3.86
CNBP CCHC-type zinc finger, nucleic acid binding protein -3.85
MORF4L2 Mortality factor 4 like 2 -3.80
doi:10.1371/journal.pone.0049045.t003
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damage as well as in homologous recombination (HR) during
meiosis, and maybe also mitosis. Thus, we speculate whether
ALKBH7 might function in general regulation of cellular
responses to repair of DNA double strand breaks by homologous
recombination.
Conclusions
In the current work we have identified several partners of the
ALKBH4 protein and an analysis of these partners suggests some
processes, such as chromatin regulation and transcription, in
which ALKBH4 may play an important part. Moreover, through
analysis of global gene expression changes in response to ALKBH7
over-expression, we observed enrichment of differentially ex-
pressed genes in processes like cell cycle and spermatogenesis,
supporting the previous annotation of ALKBH7 as a cell pro-
liferation and spermatogenesis-related protein. Obviously, more
rigorous studies are required to firmly establish the possible role of
ALKBH4 and ALKBH7 in these processes, but the present study
may represent a useful starting point.
Materials and Methods
Yeast Two-hybrid Assays
Two libraries (Human Placenta RP4 and Human Fetal Brain
RP1) were screened using full-length human ALKBH4 as bait (N-
LexA-ALKBH4-C fusion). Additionally, an enzymatically inactive
ALKBH4 mutant (ALKBH4H169A/D171A; mutagenesis described
in [30]) was used as bait to screen the human placenta RP4 library.
All screens and subsequent data analysis were performed by
Hybrigenics.
Plasmid Construction
For generation of ALKBH4-ECFP and -EYFP fusion con-
structs, human ALKBH4 cDNA was subcloned between the
EcoRI and BamHI sites of the pECFP-N1 and pEYFP-N1 vectors
(Clontech), respectively. To prepare the AF9-EYFP plasmid, AF9
(IMAGE-5298142) was PCR amplified (primers AF9-fwd and AF9-
rev, primer sequences can be found in Table S1) and cloned into
the XhoI/KpnI site of pEYFP-N1. pSXG-p300BP [41] was used
for amplification of the bromodomain and PHD finger encoding
fragment of p300 (primers p300BP-fwd and p300BP-rev), which was
cloned into the XhoI/EcoRI site of pEYFP-C1 (Clontech),
generating the EYFP-p300BP plasmid. To ensure nuclear access
of the EYFP-p300BP fusion protein, a sequence encoding a nuclear
localization signal (NLS) was subsequently PCR amplified from
pCMV-nucEGFP-BP-HA (kindly provided by R. Aasland) using
primers NLS-fwd and NLS-rev, and cloned into the EcoRI/KpnI
site of the EYFP-p300BP plasmid. The ENL open reading frame
was amplified from pBSIISK+ENL (kindly provided by R. Slany),
using primers ENL-fwd and ENL-rev, and cloned into the XhoI/
KpnI site of pEYFP-N1 (Clontech), generating the ENL-EYFP
construct. A fragment encoding the N-terminus of ENL (aa 1–141)
was amplified (primers ENL-fwd and YEATS-rev) and cloned into
the XhoI/KpnI site of pEYFP-C1, resulting in the EYFP-
ENLYEATS construct, encoding a YEATS domain fusion. The
XhoI/KpnI site was also used for cloning of the ENLC-EYFP
fusion construct (primers ENLC-fwd and ENL-rev), in which the
YEATS domain encoding part was deleted (aa 142–559).
For generation of inducible, stable cell lines expressing either
ALKBH4, ALKBH4H169A/D171A or ALKBH7 (described below),
the respective cDNAs were amplified (primer sequences can be
found in Table S1) and cloned between the BamHI and EcoRV
sites of pcDNA5/FRT/TO (Invitrogen), resulting in the plasmids
pcDNA5/FRT/TO-ALKBH4, pcDNA5/FRT/TO-AL-
KBH4H169A/D171A and pcDNA5/FRT/TO-ALKBH7. A FLAG
epitope tag was introduced in the reverse primers for simple
detection of the proteins. All constructs were verified by DNA
sequencing.
In vivo Acetylation Assay
The assay was performed essentially as previously described in
[68]. Briefly, plasmids encoding FLAG-ALKBH4 (pCIneoB-
3xFLAG-ALKBH4) and p300 (pCMVb-p300) were transiently
co-transfected into HCT116 cells using FuGene6 (Roche)
according to the manufacturer’s specifications. Empty vectors
were used as controls. Twenty four hours after transfection, the
cells were treated with the deacetylase inhibitor Trichostatin A
(TSA, 2 mM) for 30 minutes or left untreated. Total cell extracts
were prepared in lysis buffer (50 mM HEPES pH 7.9, 420 mM
NaCl, 0.5% NP-40, 1 mM phenylmethylsulfonyl fluoride (PMSF),
0.5 mM dithiothreitol (DTT) and Complete protease inhibitor
cocktail (Roche)). Subsequently, 1–2 mg total cell extract and 2–
5 mg anti-FLAG antibody (Sigma F3165) was used for immuno-
precipitation of FLAG-ALKBH4. The resulting precipitates were
analyzed by Western blotting using an anti-acetyl-lysine antibody
(Upstate 06-933) followed by reprobing of the membrane with the
anti-FLAG antibody.
GST Pull-down Assay
The TNT T7 Quick for PCR DNA system (Promega) was used
according to the manufacturer’s descriptions to produce in vitro
transcribed/translated [35S]-methionine labelled ALKBH4 in
Figure 4. Ectopic ALKBH4 expression does not change H3K79
methylation levels in vivo. As analyzed by Western blotting, all three
methylation states (mono- di- and tri-methylation) of the H3K79 residue
remained similar in histones purified from stable HEK293 transfectants
after doxycycline-dependent over-expression of either ALKBH4 or an
enzymatically inactive mutant (ALKBH4H169A/D171A), compared to the
equivalent, non-induced cells. Signal intensities of bands corresponding
to methylated histones were quantified using ImageJ [69], and
normalized to the total histone H3 load, but no effect of ALKBH4
overexpression was detected (not shown).
doi:10.1371/journal.pone.0049045.g004
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presence of Redivue L-[35S]-methionine (GE Healthcare). To
minimize production of truncated protein products due to partly
degraded mRNA, 10–15 mg RibonucleaseA (Sigma) was added to
the reaction mixtures subsequent to translation and further
incubated at room temperature for 10 minutes. GST fusions of
ENL and p300BP were separately expressed in E. coli, immobilized
on Glutathione Sepharose resin (GE Healthcare) and washed with
interaction buffer (50 mM Tris-HCl pH 8.5, 12 mM NaCl,
0.1 mM ZnAc, 150 mM KCl, 2 mM MgCl2, 10 mM 2-mercap-
toethanol, 0.1% Triton X-100). In vitro translation reaction
mixture (5–10 ml) was added to the immobilized GST-fusion
proteins, which were incubated with gentle agitation for 30 min at
room temperature. Reactions were subsequently subjected to four
washes with interaction buffer and one wash with 50 mM Tris-
HCl pH 8.0 prior to elution with GST-elution buffer (50 mM
Tris-HCl pH 8.0, 15 mM reduced glutathione, 0.1 mM ZnAc).
Similarly, reciprocal pull-downs using GST-ALKBH4 and [35S]-
labelled p300BP (alternatively full-length p300) were also per-
formed. GST-only was included as control. Eluted proteins were
analyzed by SDS-PAGE followed by phosphor imaging using LE
Storage Phosphor Screens (GE Healthcare) and an exposure time
of 1–4 days. Signals were visualized in a TyphoonTM 9400 scanner
(GE Healthcare).
Co-immunoprecipitation
Plasmids encoding HA-tagged versions of ENL, AF9 or p300BP,
or the empty vector (pCMV-script, Stratagene), were separately
transfected into Flp-In-293-ALKBH4 cells (described below) using
FuGene6 (Roche) according to the manufacturer’s descriptions.
Cells were treated with 2 mg/ml DOX to induce expression of
FLAG-tagged ALKBH or left untreated. After 18–24 hours, the
cells were harvested in phosphate-buffered saline (PBS) and
washed once in PBS before 5–66106 cells were subjected to
crosslinking in PBS with 0.125–0.25% formaldehyde for 20
minutes at 37uC. The crosslinking reaction was stopped by the
addition of 0.15 M glycine followed by incubation on ice for 3
minutes and subsequently at room temperature for 2 minutes.
To prepare cell extracts, the cells were washed twice with PBS
and resuspended in 3 volumes (,200 ml) of Buffer I (20 mM
HEPES pH 7.9, 1.5 mM MgCl2, 100 mM KCl, 0.2 mM EDTA,
20% glycerol, 0.5% NP-40, 1 mM DTT, Complete protease
inhibitor cocktail (Roche)) containing 2 ml Omnicleave Endonu-
clease (200 U/ml Epicentre Technologies) followed by sonication,
addition of DNase/RNase cocktail (200 U/ml Omnicleave Endo-
nuclease, 250 U/ml Benzonase (Novagen), 30 mg/ml RNase
(Sigma-Aldrich), 10 U/ml DNase (Roche), 100–300 U/mg micro-
coccal nuclease (Sigma-Aldrich)), incubation with gentle agitation
for 1 hour at room temperature and subsequently over night at
4uC. The extracts were cleared by centrifugation at 14,0006g at
4uC for 10 minutes.
Immunoprecipitation was performed by pre-incubating the cell
extracts with 2–5 mg anti-FLAG antibody (Sigma F3165) in 5 ml
Buffer II (20 mM HEPES pH 7.9, 1.5 mM MgCl2, 100 mM KCl,
0.2 mM EDTA, 10% glycerol, 1 mM DTT, Complete protease
inhibitor cocktail (Roche)) at room temperature for 1 hour.
Subsequently, 50 ml 10% Sepharose rec-Protein G (Invitrogen)
was added and the samples were incubated with gentle agitation at
4uC for 1 hour. After extensive washing with Buffer II the
immunocomplexes were resuspended in Laemmli buffer. Cross-
links were reversed by incubating the samples at 70uC for 10
minutes followed by addition of 0.1 M DTT and further
incubation at 95uC for 30 minutes. Immunocomplexes were
analyzed by SDS-PAGE and Western blotting using an anti-HA
antibody (Abcam Ab9110), and membranes were reprobed with
the anti-FLAG antibody.
Confocal Imaging
Live HeLa S3 cells (ATCC) were examined 16–24 h after
transient transfection (using FuGene 6 or FuGene HD (Roche)
according to the manufacturer’s recommendations) of the ECFP/
EYFP/RFP fusion constructs. The fluorescent images were
acquired using a Zeiss LSM 510 Meta laser scanning microscope
equipped with a Plan-Apochromate 636/1.4 oil immersion
objective. The images were acquired in the growth medium of
the cell, with the stage heated to 37uC, using the Zeiss LSM 510
software. ECFP was excited at l=458 nm and detected at
l=470–500 nm and EYFP was excited at l=514 nm and
detected at l=530–600 nm. The thickness of the slice was
1 mm. All images were acquired with consecutive scans to avoid
bleed through. No image processing, except contrast and intensity
adjustments, were performed.
Establishment and Maintenance of Stable, Inducible Cell
Lines
Inducible cell lines for stable over-expression of FLAG epitope-
tagged versions of ALKBH4, ALKBH4H169/D171A and ALKBH7,
respectively, were generated using the Flp-InTM T-RExTM System
(Invitrogen) and the Flp-InTM T-RExTM-293 host cell line
(Invitrogen, R780-07), according to the manufacturer’s specifica-
tions. This system ensures isogenic cDNA expression from a single
transcriptionally active genomic locus. Briefly, pcDNA5/FRT/
TO-ALKBH4, pcDNA5/FRT/TO- ALKBH4H169/D171A and
pcDNA5/FRT/TO-ALKBH7 (described above) were indepen-
dently co-transfected with the Flp recombinase-encoding
pOGG44 vector into the Flp-InTM T-RExTM-293 host cell line,
using FuGene6 transfection agent (Roche). Selection of transfec-
tants was performed in presence of 200 mg/ml Hygromycin B
(Clontech). Single colonies conferring hygromycin B resistance
and zeocin sensitivity were expanded and treated with doxycycline
(Clontech). Total cell extracts were prepared using RIPA lysis
buffer (Santa Cruz), according to standard methods, and screened
for ALKBH over-expression by Western blotting (described
below). Stable transfectants were maintained in Dulbecco’s
modified Eagle’s medium (DMEM) (Lonza) supplemented with
10% tetracycline-free fetal bovine serum (FBS) (Clontech), 100 U/
ml penicillin (Lonza), 100 U/ml streptomycin (Lonza), 2 mM L-
glutamine (Lonza), 15 mg/ml blasticidin-S (Invitrogen) and
200 mg/ml hygromycin B. Ectopic ALKBH expression was
induced by addition of 2 mg/ml doxycycline (DOX) to the
medium. For microarray analysis, transgene expression was
induced at a cell confluence level of approximately 50%. Cells
were harvested 48 hours after induction. All samples were
prepared in triplicates.
Histone Purification
Histones were purified from Flp-InTM-293 cells (Invitrogen)
containing a stable, doxycycline-inducible integration expressing
FLAG-ALKBH4 or FLAG-ALKBH4H169A/D171A (described
above), either treated with doxycycline or untreated, using the
Histone purification mini kit (Active Motif) according to the
manufacturer’s specifications. Briefly, cells were lysed in Extrac-
tion Buffer at 4uC for 1 hour. Cleared lysates were neutralized and
loaded onto pre-equilibrated spin columns which were washed
prior to histone elution. Purified histones were subsequently
concentrated by perchloric acid precipitation.
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Antibodies and Western Blot Analysis
Total cell extracts or histones were subjected to separation by
SDS-PAGE (NuPAGEH SDS-PAGE Gel System, Invitrogen) and
transferred onto Invitrolon PVDF membranes (Invitrogen).
Membranes were subjected to blocking with 5% dry milk in
PBS with 0.1% Tween-20 (PBS-T) for 1 hour. After incubation
with primary antibody diluted in PBS-T with 5% dry milk for 1
hour, the membranes were washed three times with PBS-T,
incubated with secondary antibody diluted in PBS-T with 2,5%
dry milk for 1 hour and subjected to three additional washes with
PBS-T. Primary antibodies used were anti-FLAG (Sigma F3165),
anti-HA (Abcam Ab9110), anti-GAPDH (Applied Biosystems
AM4300), anti-acetyl-lysine (Upstate 06-933) anti-H3K79me1
(Abcam ab2886), anti-H3K79me2 (Abcam ab3594), anti-
H3K79me3 (Abcam ab2621) and anti-H3 (Abcam ab1791). While
the anti-H3K79me1 and anti-H3K79me3 antibodies were specific
towards mono- and trimethylated H3K79, respectively, anti-
H3K79me2 antibody specificity towards dimethylated H3K79 was
ensured by pre-incubating the antibody with two H3 derived
peptides containing either mono- (Abcam ab4555) or trimethy-
lated (Abcam ab4557) H3K79 (1 mg/ml of each) for 30 min at RT
before incubation with the membrane, thereby blocking mono-
and trimethyl reactive sites (data not shown). Anti-FLAG and anti-
GAPDH antibodies were used in combination with an alkaline
phosphatase-conjugated secondary antibody and the Amersham
ECF detection system (GE Healthcare). Fluorescence signal
detection was performed in a Typhoon scanner 9400 (GE
Healthcare). The remaining antibodies were used in combination
with a horseradish peroxidase-conjugated secondary antibody and
the SuperSignal West Dura kit (Thermo Scientific). Chemilumi-
nescence signals were visualized on a Kodak Image Station 4000R
Pro instrument (Carestream Health). Densitometry was performed
using the ImageJ software [69].
RNA and Genomic DNA Isolation
Total RNA and genomic DNA were isolated from cell lines
over-expressing ALKBH4 or ALKBH7 or the equivalent non-
induced cell lines. For RNA isolation, TRIzol (Invitrogen) was
used according to the manufacturer’s descriptions. The RNA was
subsequently subjected to a clean-up step using the RNeasy Mini
Kit (Qiagen) according to the RNA Cleanup procedure in the
supplied manual. Genomic DNA was isolated using the QIAamp
DNA Mini Kit (Qiagen) according to the manufacturer’s protocol.
Quantitative PCR Analysis
SuperScript II Reverse Transcriptase (Invitrogen) was used to
synthesize cDNA, using oligo(dT)12218 primers (Invitrogen) and
5 mg of total RNA. cDNA synthesis was performed according to
the manufacturer’s specifications, except that the incubation step
prior to addition of the SuperScript II RT was omitted.
Quantitative PCR (qPCR) was performed in 20 ml reactions using
SYBR Green master mix (Qiagen), 4 ml cDNA (diluted 1:16), and
10 pmol ALKBH4-specific primers (ALKBH4-qPCR-fwd and
ALKBH4-qPCR-rev, primer sequences can be found in Table S1).
Reactions were performed on a LightCycler 1.5 instrument
(Roche). LightCycler software 3.5.3 (Roche) was used for data
analysis and quantification was performed using the DCT method
[70] with b-actin as endogenous reference (primers beta-actin-fwd
and beta-actin-rev). All experiments were performed in triplicates.
Microarrays and Data Analysis
mRNA expression and CpG methylation profiling was
performed by the Helse Sør-Øst/University of Oslo Genomics
Core Facility using the Illumina HumanWG-6 v3 Expression
BeadChip and Illumina Infinium HumanMethylation27 Bead-
Chip, respectively, according to the manufacturer’s protocols.
Data extraction and initial quality control of the bead summary
raw data were performed using GenomeStudio v2011.1 from
Illumina and the Gene Expression and Methylation module
v1.9.0. The data was annotated using the HumanWG-
6_V3_0_R3_11282955_A and HumanMethyla-
tion27_270596_v1.2 annotation files from Illumina. Unnorma-
lized bead intensities were exported into a tab delimited text file
and imported into J-express Pro (v. 2.7) for further downstream
analysis [71]. Bead intensities were quantile normalized, and rank
product analysis was performed to identify gene expression
changes [72]. A significant threshold of q-value ,5 and a fold-
change larger than 1.35 for ALKBH4 or 2 for ALKBH7 was used
to identify differentially expressed genes. Differentially expressed
genes were further analyzed in MetaCore (GeneGo) to identify
functional enrichment.
CpG methylation data was analyzed using the GenomeStudio
Methylation Module, where avgBeta (average ratio of signal from
methylated probe relative to the sum of both methylated and
unmethylated probes) was calculated and used for comparisons
within sample groups.
The mRNA expression and CpG methylation datasets have
been deposited in the GEO data repository (www.ncbi.nlm.nih.
gov/geo/, accession number GSE39135).
Supporting Information
Figure S1 Partial co-localization of ALKBH4 and ENL
with RNA Polymerase I subunit RPA43 in nucleolar
speckles. Co-expression of ALKBH4-EYFP with ECFP-ENL
and RPA43-RFP in HeLa cells, as analyzed by confocal
fluorescence microscopy. Insets are enlargements of boxed areas.
(PDF)
Figure S2 Effects of ALKBH4 and ALKBH7 over-expres-
sion on the global DNA methylation pattern. CpG
methylation profiles were analyzed in stably transfected
HEK293 cells before vs. after doxycycline induced over-expression
of ALKBH4 (left panel) or ALKBH7 (right panel), using the
Illumina Infinium HumanMethylation27 BeadChip. DOX, doxy-
cycline.
(PDF)
Table S1 Primer sequences.
(PDF)
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Bjørnstad et al. – Supplementary Figure S1
MERGEDALKBH4-EYFP RPA43-RFPECFP-ENL
Supplementary Figure S1 Partial co localization of ALKBH4 and ENL with RNA Polymerase I. -
subunit RPA43 in nucleolar speckles. Co-expression of ALKBH4-EYFP with ECFP-ENL and
RPA43 RFP in HeLa cells as analyzed by confocal fluorescence microscopy Insets are- , .
enlargements of boxed areas.
Bjørnstad et al – Supplementary Figure S2.
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Supplementary Figure S2. Effects of ALKBH4 and ALKBH7 over-expression on the global DNA methylation
pattern. CpG methylation profiles were analyzed in stably transfected HEK293 cells before vs. after doxycycline-
induced over-expression of ALKBH4 (left panel) or ALKBH7 (right panel), using the Illumina Infinium
HumanMethylation27 BeadChip. DOX, doxycycline.
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